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Retrospective Study of Inspectors Competency in the Act of
Writing GMP Inspection Report
C.U. Uche1, Z. Ekeocha2, S. Byrn3, K. Clase4 
ABSTRACT
The research was a retrospective study of twenty-five Good Manufacturing Practice (GMP) inspection reports
(from March 2017 through to December 2018) of a national medicine regulatory agency, drug Inspectorate, in
West Africa, designed to assess the inspectors’ expertise in the act of inspection report writing.
The investigation examined a paper-based tool of thirteen pre-registration Inspection reports and twelve GMP
reassessment reports written prior and following an intervention program by external GMP trainers to enhance 
inspectors’ skill in pharmaceutical cGMP inspection.
The study made use of quantitative analysis to investigate each team’s expertise in the act of writing GMP
inspection report. Likewise, each report’s compliance with the requirements of three regulatory standards on GMP
inspection report writing was ascertained. Impact of intervention program on lead inspectors’ competence was
assessed. Lastly, gap in each team writing effectiveness, and lead inspectors’ abilities to deliver an effective report
were determined.
The results showed one of the inspection team (4.0%) wrote an excellent report. Two (8.0%) of the twenty-five 
inspection teams penned good inspection reports. Eleven (44.0%) teams drafted needs improvement reports and
the remaining eleven teams (44.0%) prepared unacceptable reports.
The excellent report and the two good reports had report format that meet expectation. One (50.0%) of the good
reports showed the authors possess excellent knowledge of cGMP technical areas. The remain good report
(50.0%) revealed the writers’ knowledge.as good. The excellent report showed the authors displayed partial
mastery in the use of objective evidence while the two good reports disclosed theirs as having partial and evolving
abilities. One of the teams (50.0%) that wrote good reports displayed good use of third person narrative past 
tense in report writing whereas the other team used the same tense and voice excellently.
Generally, a sort of marginal level of performance was prominent among the inspection teams. A gap, if not tackled, 
will slow down regulatory process through increase report review, litigations that query report factual accuracy
(AIHO, 2017) and delay in issuance of marketing authorization.
In conclusion, trainings on quality attributes, such as technical content (Quality Management System (QMS) and
Site), the use of objective evidence, assignment of risk levels to GMP violations and citing of applicable laws, 
regulation and guidelines that substantiate GMP observations, were recommended, to enhance knowledge
sharing and regulators’ performance in the act of writing inspection report.
KEYWORDS: Regulatory System, Good Manufacturing Practice, Pharmaceutical Inspectors, Inspectional
observation., Inspection report, compliance letter.
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2 
Introduction
Knowledge and skill to write competently and in a way
which suits one’s goal and audience is a task which 
many individuals never acquire in their first language,
even with the fact that significant part of the
educational process is devoted to developing of such 
skills (May, 2015). Information sharing in a diversity of
written formats and for array of reasons is an act that
leads to analytical, critical, and logical thinking
(Fasset, 2019).The old saying that, “A job is not
complete until the paperwork is over,” is partially
correct (Fasset, 2019).Invariably, it should `be
understood that an effective report, is one which the
author need to articulate his or her point and relay the
information in such a manner that the reader will
understand exactly what he or she means (Your
dictionary, 2002).This means that reports have to be
presented as organised information based on sound
evidence that would unavoidably, lead to a logical
conclusion (Smyth, 2012). This educational skill is
highly valued by employers and should be assessed
from time to time, especially where what one writes
and how well he or she writes it, can affect people’s
lives (Smyth, 2012).
Writing competence” is defined as possessing the 
required writing abilities to produce an orderly use of
words. With the support of written statement, it is
likely to communicate with individuals who are not 
with us. The act of writing can be used to discern our
thoughts, and to visualize the realities of existence as
well as things that are yet to happen. Basic writing
competence was defined as the ability to make
effective use of basic writing functions such as
purposeful, in written art and handicraft. Through
purpose writing we share information for different
reasons in different situations. It could be through text,
words, spelling, sentences, composition and drawing
as well as other signs in written art and handicraft we
engage the intellectual, psychological, and physical
parts of skills to provide us with a well-written
document for a brilliant presentation (Kjell Lars Berge,
2009).
The aim of writing is often associated with the nature
of activity that goes on in a particular area. Therefore,
the way of writing in particular discipline reflect their
specific ideology, internal reason, and work ethics
(Kjell Lars Berge, 2009). FDA employees across the
globe write a range of documents, which include but
are not limited to letters and web content for a variety
of audiences, guidance documents, regulations,
compliance directives, consumer safety notices and 
updates, recall notices, warning letters, press
releases, policies and procedures and GMP reports in
some climes(FDA, 2019).The high volume and wide 
range of documents these employees handle, made it 
essential that the competence of the regulators
involved in this task be assessed periodically, to
assure adherence to good documentation procedures
and good report writing practice. This would not only
foster accountability and transparency in drug 
regulatory process but would assure the consistency
of information and associated GXP (Good Whatever
Practice) (WHO, Guidance on good data and record
management practices, 2016).
Internationally, the World Health Organization (WHO)
guesses that minimum of 30% of National Medicine 
Regulatory Authorities (NMRAs) have partial capacity
to carry out their core regulatory functions. In Africa,
there are 54 NMRAs with different capabilities to
perform regulatory tasks (Ndomondo-Sigonda, Miot, 
Naidoo, Dodoo, & Kaale, 2017). Most of these had
fragmented regulatory systems which on several
occasions had been linked to weak legal and
regulatory framework. Gaps and overlaps of
responsibilities were common, especially in licensing 
(involving the Ministry of Public Health or Ministry of
Trade) and inspection (involving pharmaceutical
councils, regional authorities, or public health
inspectorates). Organizations of this type have limited
autonomy (WHO, Regulatory Harmonization:, 2010).
An assessment of 26 regulatory systems in sub
Saharan Africa revealed that all of them had critical
weaknesses, including a lack of sustainable funding 
and a severe lack of human resources (USAID, 2018).
Most of these NMRAs lack sufficient competent staffs
to realise their mandate. Competency is missing in 
core regulatory functions, such as clinical trials
monitoring, inspection of facilities Inspection report
writing, dossier review, bioequivalence data
evaluation, quality management systems
pharmacovigilance and post-marketing surveillance
(Ekeigwe, 2019). In some cases, an unqualified 
individual without professional expertise and hands-
on knowledge of regulatory science due to his/her
background or political connection, becomes
employed into an NMRA. Some of these individuals
with minimal regulatory knowledge and experience, in
a short space of time ascend to positions where





    
    
      
     
    
    
       
     
     
     
      
       
      
   
     
     
    
    
       
      
      
      
      
    
       
   
   
  
    
  
       
    
   
     
   
    
    
     
   
   
       
   
      
      
     
   
     
   
      
      
    
     
       
     
   
    
   
    
    
      
    
     
   
  
 
    
    
      
    
     
     
    
      
     
     
    
      
      
     
     
    
   
   
    
    
     
  
      
  
 
    
 
 
   
   
     
     
     
    
   
   
     
      
  
      
3 
Consequently, this creates bottlenecks because their
lack of expertise often results in slow decision making
in situations that should otherwise call for prompt
action in the interest of public health. Also, the 
inability of most regulators to get expose to regulatory
sciences and medicine regulation courses during their
early career days in pharmacy schools, science
departments, and other academic institution, explains
their poor performance in execution of their assigned
tasks. Occasionally, these employees may or may not
have the privilege to be trained by their employers. On 
the job training becomes the only available option 
through which fresh employees struggled their way to
learn (Ekeigwe, 2019).
Strong regulatory systems are required to guarantee
the quality, safety, and efficacy of medical products
and advancement of trade and socioeconomic
development. The strictness in regulation activities
should be guided by the type of the drug formulation,
questions asked during product safety, quality, and
usefulness evaluation, and by complexities of the
pharmaceutical supply chain. All nations then need to
have functional and competent national medicines
regulatory authorities (NMRAs) (Ndomondo-Sigonda,
Miot, Naidoo, Dodoo, & Kaale, 2017) or else make it
would make regulatory processes excessively
complicated, lengthy, and lacking in transparency
(USAID, 2018).
Inspection of manufacturing facilities to assess their
compliance with current good manufacturing practice 
(cGMP) regulations is one of the core functions of
National Medicine Regulatory Agency (IAuditor, 2020).
Health risks due to factors like poor hygiene,
inadequate temperature-control, cross-
contamination, adulteration etc in any step of the
manufacturing process, could lead to fatal
consequences to consumers. As such, Good
Manufacturing Practice (GMP) is implemented by
many manufacturers around the world. It is mandated
by individual countries government to regulate 
production, verification, and validation of
manufactured products to ensure that they are of
good quality, effective and safe for market distribution.
For instance, in the United States of America, GMP is
enforced by the US FDA through Current Good 
Manufacturing Practices (CGMP) which covers a 
broader range of industries such as cosmetics, food,
medical devices, and prescription drugs (IAuditor,
2020). When a manufacturing site for pharmaceutical
products is assessed, the inspection team that carried
out the audit normally draw up a report which detail
the outcome of observations made during the
exercise. The ability of inspectors to write clearly for a
general audience, as well as the ability to adapt their
mode of writing to different audiences and purposes,
are important competencies they should possess
(Cyn et al, 2014). Success in this area depends much 
on the level of the inspector’s proficiency, his
readiness to learn and the open-mindedness to have
the report reviewed to get more constructive 
feedbacks on his or her performance. This is not the 
case with many regulatory inspectors in West Africa. 
Issues on deficiencies in inspection report writing 
practice have been areas of great concern which
require attention. These areas of concern include.
Non-uniform application of common standards or
principles (Requirement, Evidence and Deficiency)
that guide GMP inspection report writing. (WHO
2016a). Incomplete capturing of some sections or sub
sections stipulated in the inspection report format of
the NMRA. Non-usage of third person narrative past
tense writing style (WHO 2016a). Listing of observed
deficiencies under a wrong GMP system or sub-
system. Inspectional observation(s) not made clear
and specific. Repeat of observations and non-ranking
of the violations in order of significance. Wrong
citation or non-citing of applicable sections of the laws
and regulations administered by the FDA (Gutting,
2013).that validate inspector’s opinion on violation.
Capturing of violations under wrong risk-based
classification status. Non-reporting of GMP systems
or sub-systems “NOT INSPECTED” or VERIFIED. 
Conflicting information in the report or subtle addition
of non-existent observation in the report. Evasiveness
in making categorical statement on GMP status of the 
auditee (whether it is satisfactory. marginal or
unsatisfactory). Non-endorsement of report by one or 
two members of the inspection team. At the end,
timely submission of Inspection report.(WHO 2016a)
Resources and Guidance Documents for
Compliance Monitoring
WHO TRS No. 996 2016, Annex 4 provided a 
reviewed guidance on good manufacturing practice
for National Medicine Regulatory Authorities. The 
document described the common principles and
suggested standardized report format to be used by
regulatory authorities and other establishments that
perform pharmaceutical Inspections. In line with the
provision of this document, writing inspection reports
must produce a accurate and unbiased information on
activities carried out. Inspection rating comments
(both compliant statement and non-compliant





      
      
      
     
     
       
   
  
     
     
   
  
   
     
   
      
     
      
   
  
     
       
       
     
       
    
 
    
 
 
     
       
    
     
       
     
     
      
     
    
   
    
    
 
     
     
  
    
   
     
        
  
     
   




         
        






    
 
 
      
  
      
   
      
   
      
     
        
    
 
   
     
     
       
    
   
     
    




are discussed with the firm’s management during the
close out meetings and conclusion is reached at the
time the report is written(WHO, 2016). The second 
reference document on GMP inspection report writing
is WHO Technical Report Series, No. 902, 2002
Annex 8, section 7.4 p 108 on Quality Systems
Requirements for National Good Manufacturing 
Practice Inspectorates. This particular document
discussed the need for reports to be signed and dated
by inspectors,(WHO 1992). The third document is
Pharmaceutical Inspection Convention and 
Pharmaceutical Inspection Co-operation Scheme
guidance document (PIC/S PI 013-3 1 Annex 25
September 2007) on Standard Operation Procedure
for PIC/S Inspection report format which provided 
guidance on the format to be used for preparation of 
PIC/S inspection reports(PIC/S 2007). All these
regulatory standards emphasized the need for the
report to be clear, accurate and evidence-based, with 
explanation of activities, systems, procedures,
processes, and other observations made during the
audit. Based on this, conclusion can be reached that
GMP inspection report should be such a write up that 
can easily assist the target audience, to address
observations made during their facility audit, without
any dispute over observation. (Pharmalex, 2019).
Background Information About the Research
Problem
In one West Africa nation, the National Medicine
Regulatory Agency (NMRA) is the Health Regulatory
Agency (HRA) identified as overseeing
pharmaceutical products regulation. This is an agency
under the ministry of health established by the
provisions of the food, drug and cosmetic act in sub-
section xi a and b, section 42 of the country’s 1952 
drug law. The primary goal of the organization is to
ensure the safe use of food, medicines and cosmetics
products for beneficial health purposes while
protecting people against harmful effects of 
counterfeit and substandard medicines and
unwholesome processed food (Geno & Kim, 2019).
The Inspectorate of the NMRA is an independent arm 
that is charged with the responsibility of assessing
pharmaceutical manufacturers compliance with good 
manufacturing practice regulations for medicinal
products. Though the department had been 
established many years ago, yet the issue of low
expertise in the act of writing GMP inspection report,
was found to be common among her inspectors. 
(Please see Figure 1 for more information). The
challenge which manifested in the form of non-
uniform usage of approved report format, poor
knowledge of technical requirements of GMP, 
ineffective use of objective evidence to support
observations, providing evasive answers to inspected 
facility GMP status etc., had over time affected the
quality of reports written by their inspectors (WHO,
Guideline on Implementation of Quality Management











Tackling Ineffective GMP Inspection report writing in
National Medicine Regulatory Agency
The challenge was earlier blamed on the use of
decentralized procedure which empowered the
regional offices to handle inspection activities under
their territory. Much later, it was found that 
subsequent adoption of a centralized approach which
ceded the mantle of co-ordination to the inspectorate 
head office, did not reduce the anomalies. No data on
how this deficiency impacted regulatory function of 
the organization was provided. As such, the level of
the inspectors’ competence in the act of inspection 
report writing and the bottlenecks which it had created 
so far were yet to be quantified. Secondly, the
Agency’s policy on sharing reports with auditees was
another area of concern. This is because murky
reporting has factual accuracy problems that can
negatively affect company’s response to inspectional
observations. Thus, leading to re-observation of
poorly captured violations during a re-inspection of
the facility’s corrective actions effectiveness. Thirdly,
the organization’s effort to become one of the
5 
regulatory partners in regulatory reliance initiative 
would suffer a set-back. Reason being that poor 
report writing practice, would cast doubt on the 
Agency’s capability to assure acceptable level of 
GMP compliance. Other setbacks include, 
accumulation of un-cleared drug products’ registration 
applications, delay in issuance of marketing 
authorization (Ekeigwe, 2019) as revealed in Figure 
2 below. Multiple cycles of report review, increase in 
process time for report evaluation, increase in 
regulatory burden for few proficient inspectors, failure 
of the inspectorate to meet the administrative process 
timelines. At last, delay in conveyance of observations 
to regulated subjects (both local and foreign clients). 
Poor Regulation Limited Know-how 
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Figure 2
Venn diagram characteristics that illustrated the
effects of Ineffective GMP Inspection Report writing.
Based on these findings, the research intended to
identify the proficiency of the study NMRA inspectors
in the act of GMP inspection report writing. The gaps
that exist in the inspectors’ writing practice and make
recommendations on how the deficiencies could be
overcome to meet the desired competence approved
by internationally best practice.
Aim of the Study.
The purpose of the research was to conduct a 
retrospective study of a National Medicine Regulatory
Agency (NMRA) inspectors’ competence in the act of
writing GMP inspection report.
Objectives
a. To identify the appropriateness of the reports
through evaluation of their coverage and
practice attributes.
b. To find out the impact of intervention program
on inspectors’ writing performance. 
c. To verify the individual reports’ compliance
status with regulatory standards for writing 
inspection report.
d. To demonstrate the competence of lead
inspectors in the act of writing GMP
inspection report. 
e. To identify the gaps that need to be tackled to
guarantee quality improvement of GMP
inspection reports writing practice among
NMRA drug Inspectors.
Research Questions
The subsequent opinions guided this research.
a. Does the review of NMRA establishment 
inspection reports reveal the capabilities of 
drug inspectors to effectively rate
pharmaceutical industries compliance with 
cGMP requirements on medicinal products
manufacture?
b. To what extent does a few days GMP training,
by an aid agency impact the writing 
effectiveness of GMP inspectors in West 
Africa?
c. Does educational qualification and 
experience of lead inspectors affect their
capability to organize an effective GMP
inspection report?
Need for Pharmaceutical Regulation
Pharmaceutical manufacturing and management are
a complex endeavor. It involves multiple companies
and stakeholders, a myriad of sites, complex multi-
level supply chains, and many national and
international requirements and regulations that must
be met to assure the quality of medicines being
produced. This is further complicated by strong
competition within the industry and shifting market 
forces, which drive frequent supply and demand





   
       
    
     
     
   
 
 
   
     
    
   
     
   
    
      
    
        
     
     
       
      
   
 
     
     
   
    
     
    
     
    
      
     
       
       
   
  
 
                                                              
 
      
      
      
  
     
       
   
  
    
    
  
     
     
   
    
     
     




   
     
        
     
    
     
    
      
    





     
   
    
     
      




     
      
      
      
     
     
    
  
      
     
  
    
  
 
      
      
6 
systems, structures, processes, and practices which
ensure that medicines are consistently produced in
compliance with requirements, specifications, 
guidelines or characteristics appropriate to their
intended use and as demanded by the product 
parameters are referred to as GMP (WHO, 2007). The
question is what is GMP?
What is GMP?
According to WHO, Good Manufacturing Practices
(GMP) is defined as that part of organizational
resources which guarantees that products are
constantly produced and controlled accordingly. This
implies that there should be strict adherence to
standard requirements, specifications, guidelines, or 
characteristics appropriate to the product’s intended
use and as required by the marketing authorization,
clinical trial studies or product specification. The
primary objective of GMP is to manage and reduce
the intrinsic risks in pharmaceutical production to
assure the highest standard of quality, safety, and
efficacy of products and no harm in processes that
involves the making of well-being products (Geyer ,
Varley , & Damaris, 2018).
This implies there should be definite manufacturing
procedures, justified critical production steps, suitable
sites, and warehouse management system. Other
requirements include transport, trained and
competent production and quality control staffs,
adequate quality control laboratory facilities, and 
officially approved written procedures and instructions. 
Documentary evidence of compliance to all steps in
the approved procedures, effective batch traceability
system, complaints investigation and product recall
system are equally important. Conclusively, the
effective implementation of GMPs not only supports
but equally help to guarantee the safety, efficacy, and
quality of medicines (Roth L, et al,, 2017).
Who is a GMP Inspector?
According to Neil Gunning ham (2012), “being a good
inspector is a job that requires great effort and
determination to carry out his job in the face of
daunting challenges that confront him. GMP
Inspection is an activity which can impact a
company’s viability and may lead to regulatory actions
such as product recalls, loss of sales, placing of 
manufacturing lines or entire facilities.
on “HOLD” where gross violations are uncovered and 
a negative corporate image for the firm (Woodcock,
2012.). Consequently, an inspector should be an 
individual, who is skillful at objectionable condition
identification and assessment; an expert at systems
engineering; competent at regulatory requirements
interpretation; and have good intermediary skill.
Bearing in mind, that manufacturing site inspections
are often a disliked event with regulated entities, the 
inspector needs to be firm in execution out his or her 
duty. 
Role of GMP Inspector
Regulatory compliance assessment of inspected
manufacturing sites against the requirements of 
national legislation is identified as the key role of an
inspector. Here, the suitability of a site for the activities
which it sought permit or the one it has already gotten
authorization was evaluated. The inspector was
expected to give technical advice and guidance to
both internal and external customers of the FDA. He
offered support to the implementation and execution
of national regulations in relation to matters that 
concern medicinal products (Health Product 
Regulatory Authority, 2018).
Competence of GMP Inspector
To assure a universally appropriate and flexible
competency framework which support systematic
strengthening of regulatory professionals. was
developed by WHO. Based on this, the word 
“competency” was defined as the knowledge, skills,
attitudes, and behaviors developed through education,
training, and experience (Bruno, Ian, Tina, & Claire, 
2019).
Criteria for Rating Competency of GMP Inspectors.
Since verification of the licensee’s compliance with 
statutory requirements in the authorization is the main 
goal of GMP inspection, the criteria for assessing the
performance of an inspector were listed as follows.
• His or her ability to comprehend the
regulatory body’s requirements for
conducting inspection.
• The inspector’s capacity to consider other
regulatory entities’ remarks during the
inspection process.
• Aptitude to come up with an action plan for
specific facility inspection.
• Capability to identify safety concerns and





     
     
 
    
     
      
 
      
   
 
   
  
   
     




    
   
   
    
 
  
   
   
  
   
    
    
   
   
  
 





     
     
   
      
    




    
 
 
    
     
   
   
 
 
   





make assessment on the safety of a
manufacturing site and its regulatory
compliance status.
• Ability to recognize when immediate actions
were required to rectify non-compliance if
there was imminent likelihood of a safety
significant event.
• His or her ability to guide on how to unravel
the root cause analysis of an objectionable
condition.
• Good understanding of how to use risk-
based approach at carrying out an
inspection exercise (IAEA, 2013).
These recommendations were corroborated by WHO
guidance on quality systems requirements for national
good manufacturing practice inspectorates which
proposed specified competency requirement of GMP
inspector which are,
• GMP inspectors should have the requisite
self traits of tact, integrity, courage, and
character to carry out his obligations.
• He or she should be educationally skilled in 
a recognized scientific/technological field 
that relate to pharmaceutical sciences. 
(Relevant knowledge in pharmaceutical
manufacture could be considered an added
advantage).
• Having participated in a cross functional
training course on inspecting GMP systems.
• Possessing sufficient working knowledge of 
several regulatory guidelines on GMP for
pharmaceutical products and/or relevant
national regulatory authority GMP inspection
procedures.
• Having undergone appropriate training in the
current procedures and techniques of GMP
inspections before conducting an inspection
(WHO, 2002).
Competency Measurement Model
The flow chart of competency analysis model in figure
3 summarized the need for management of a
regulatory authority to evaluate prevailing
competences of their staff, by relating the current with
Ideal competences, execution of gap analysis study
and priority areas selection for necessary action. 
GMP Inspection Writing
According to Association of Southeast Asian Nations
(ASEAN) Guideline on GMP for Traditional
Medicine/Health Supplement. the term “GMP
inspection report writing” was defined as that type of 
writing where inspectors of an audited facility
compiled facts of inspectional observations in a
simple manner, using standard GMP inspection report 




































                                             
                                                                          
                                                                




   
      








          



























Competence Analysis flow Chart (IAEA, 2013)
Competence filling process







    
   
     
     
   
      
    
      
      
 
 
   
 
      
  
   
      
 
    
 
    
    
   
       
        
    
   
   
    
    
      
     
     
       
   
 
    
    
    
       
       
     
       
     
   
     
    
   
    
     
      
      




     
       
     
     
    
     
    
   
    
   
   
     
     
  
    
     
     
    
          
   
    
       
    
     
   




     
   
      
  
 
    
  
  




   
  
    
    
      
8 
report at the end of the report and signature of the 
inspectors (ASEAN, 2017). This agreed with the
provisions of WHO guidance on Inspection reports
which stated the aim of writing an inspection report is
to produce accurate and unbiased information on 
activities carried out, findings made whether positive
and negative for each inspected area, as made known
to the company during the close out meetings and a
conclusion that was reached at the time the report
was written.
By this, the above statement supported the fact that.
If it is not documented, then it never happened.
However, in the case of ineffective GMP Inspection 
report writing, I would rather state that.
If it was “not documented correctly”, it happened, but
in “deplorable style.
Procedure for NMRA GMP Inspection Report
Writing
Upon completion of an inspection, the report is
prepared by the designated member of the inspection 
team using a list of discrepancies written during the 
inspection as noted in the NMRA inspector’s
notebook. The team provides in the report facts of
observations (both compliant statement and non-
compliant remarks) made during the audit as outlined 
in the applicable Inspection report format. The
inspector will ensure that the report captures the 
objectionable conditions sighted during the inspection. 
The deficiencies are written clearly without ambiguity
and classified as critical, major and others using the 
risk-based classification approach described in
Annexure 4 of the study NMRA Inspector’s guide to
GMP Assessment.
The relevant sections of the applicable NMRA GMP
guidelines and regulations where observed violations
are of regulatory significance are cited in the report.
The recommendations of the team are based on the 
audit findings on the inspected site with a clear
statement on the status of the auditee’s operations.
The inspection report is compiled, endorsed by the
inspection team, and forwarded to the divisional head
or state manager for review within ten workdays of
completion of the facility audit (NMRA, 2019.).Upon
conclusion that the report complied with standard 
practice, it is further processed for issuance of
marketing authorization where the inspected facility
GMP outcome was found satisfactory. Otherwise,
NMRA will provide guidance and timeline for the
regulated entity to develop a plan to effect corrective
actions and revert to the Agency for necessary review
(Bablani & Manthan, 2019).
Characteristics of GMP Inspection Report
The characteristics of an inspection report include
aspects such as the importance and correctness of
the information it contains, the reliability of its
arguments, its legibility, and the relevance of the
matters it covers. Such features are mostly covered in
inspection reporting standards like (WHO, Quality
Systems Requirements for National Good
Manufacturing Practice Inspectorates, 2002).
Detailed description from another guideline shows
that report template should comprise a title that aid
the reader easily understand its contents. It must 
visibly spell out the objective and scope of the
assessment task to establish its purpose and limits. 
The inspection processes that were carried out should 
be well articulated, the evidence collected, and the
analysis undertaken. The report should also be dated
to provide a timeframe and context to the reader about
the observations made during the exercise. Other 
useful "reader aids" to be included in the report are a
list of report rubrics, a keyword index, a glossary (an
alphabetical list explaining terms and abbreviations
used in the report (PASAL, 2020). Once these actions
are accomplished, report’s sharing with concerned
parties should not be a challenge to the inspectorate.
In the instance of this research, the report structure
was categorized into two key features namely the
coverage attribute and the practice attribute of an
inspection report.
Coverage attributes – Those attributes of inspection
report that bordered mainly on the reporting template,
findings made during audit and the objectivity of
evidence that described those findings. The attributes
include.
a. Use of the right inspection report format.
b. Demonstration of good knowledge of report 
technical content (Quality Management
System (QMS) and site) or elements of good
manufacturing practice,
c. Provision of objective evidence for 
Inspectional observations.
d. Use of third person narrative past tense
(WHO, 2016)
Practice Attributes – Convergence of practices that;
determine the strength of the report, provide





       
 
   
 
  
   
 
     
   
    
   
  
   
  
      
        
     
      
      
   
        
     
     
       
    
   
     
     
      
      
      
     
  
    
        
    
       
   
       
      
     
     
      
 
  
     
        
  
     
      
   
  
    
      
   
  
     
     
   
    
     
      
   
     
  
 
     
  
       
      
  
      
      
     
 
 
       
  
     
   
    
  
 
      
      
     
    
     
     
      
     
    
     
 
 
      





and finally qualify the outcome of the inspection. The
attributes are.
e. Risk-based classification of GMP
deficiencies.
f. Reference of deficiencies to applicable 
sections of the guidelines, laws and
regulations administered by the NMRA and 
other relevant bodies.
g. Signing off on an inspection report by
members of inspection team.
h. Writing and submission of the report in a
timely manner (Gutting, 2013). (Please 
Appendix 2 and 5 for details on assessment 
rubrics for GMP inspection report)
Implication of the Study
The study was relevant because, facts and findings
gathered will built on the limited data available on
inspectors’ competence, in the act of writing GMP
inspection report. The research findings on various
inspection teams writing competency would help the
agency address issues of low expertise among her 
regulators. Facts obtained from the study could be
used as baseline for future review of inspector’s report
writing abilities within the organization. The study may
serve as a guide to other regulatory authorities (FDA
and non-FDA) on how to assess the capabilities of 
their regulators in inspection report writing. 
Observations made may be of relevance to study
NMRA regional offices because it would help to instill
uniformity in their report writing abilities. Other
possible gains in the study include reduction in the 
number of report review cycles, reduced burden for
experienced lead inspectors, removal of bottlenecks
in administrative functions that relate to issuance of 
marketing authorization. Potential barriers murky
reporting will create against study NMRA effort to
partner with other national competent authorities on 
reliance initiative would be averted. The investigation
may assist other NRAs to reduce the number of report 
queries they received from auditees The goal of
safeguarding public health which ensure that auditees
comply with good manufacturing practice and assure
consumers’ access to quality, safe and efficacious
medicinal products would be achieved (Daniel , 2011).
Definition of Terms and Concepts
Current Good Manufacturing Practices (cGMP),
GMP is also sometimes referred to as "cGMP". The
"c" stands for "current," reminding manufacturers that 
they must employ technologies and systems which
are up to date to comply with required quality
approach to manufacturing (ISPE, 2021). As a result, 
strict adherence to relevant requirements, 
appropriate to their intended use and as required by
the marketing authorization, clinical trial studies or 
product specification is important.(WHO 2007).
Pharmaceutical Inspection: It is an aspect of
universal drug quality assurance system which aimed 
at enforcing Good Manufacturing Practice (GMP)
compliance or providing license for the manufacture
of pharmaceutical products. This focuses mainly on
request made by applicants of drug product
registration for marketing authorization (WHO,
Provisional Guidelines on the Inspection of
Pharmaceutical Manufacturers. , 1992).
Inspection report In GMP Context: is a 
documentary evidence used to provide accurate and 
unbiased information on activities carried out.
Findings made whether compliant statement or not for
each inspected area. Both of which are made known
to the company during the close out meetings and a
conclusion that was reached at the time the report
was written (WHO, Guidance on Good Manufacturing
Practices: Inspection Report. , 2016).
Report writing in GMP context is the type of writing 
where inspectors of an audited facility are writing and
compiling the facts of inspection observations in a
simple manner using standard GMP report format
with their conclusion at the end of the report and
signature of the inspector (ASEAN, 2017).
Inspectors in GMP context is a staff of a National
Regulatory Authority whose principal duty is to
present a comprehensive and accurate information on
standards of production activities, and control steps
relevant for the manufacture of any product. The
inspector advises on ways to improve the in-process
test procedure, or any other regulatory service which 
in his or her own view promotes the quality, safety,
and efficacy of pharmaceutical products. (WHO, 
Provisional Guidelines on the Inspection of
Pharmaceutical Manufacturers. , 1992).
An inspectional observation: is a finding or remarks
made during an inspection and authenticated by
objective evidence (WHO, Guidance on Good 






    
       
  
   
      
  
      
    
     




     
      
     
    
  
   
  
  
    
    
     
    




   
     
     
     
    
     
    
   
    
      
   
    
     
  






Regulatory System: Regulatory System means a 
framework of legal provisions on Good 
Manufacturing Practices, inspections, and
enforcements that safeguard the public health and
provide the authority to assure compliance with its
requirements (Day, 2017)
Competent Inspection team: A team of inspectors
with requisite educational background, auditing
expertise and experience in regulatory mandate that
is required for successful accomplishment of
assigned inspection duty. (World Health Organization
2019).
Regulatory Convergence and Harmonization was
described as joint activities that was based on
reliance and collaboration by various NMRAs to 
develop acceptable documentation that supports to a
large extent common approach to regulatory issues
among themselves. (Ball et al, April 2016)
2. METHODS
Design and Setting
In undertaking this study, we used purposive
sampling technique to collect (25) paper based GMP
inspection reports which comprised (13) pre-
registration Inspection reports and ten (12) GMP
reassessment reports for a period of one year and
nine months, starting from March 2017 through
December, 2018 (Conroy, 2010).
Data Collection
Retrospective data were collected from paper -based
inspection reports available on NMRA’s drug
inspectorate database. The activity took place from
8th December 2018 to 15th February 2020 which 
depicted a two or more days collection interval for a
single report. Review of these reports was
accomplished using tools like NMRA drug
Inspectorate inspection format, NMRA drug
Inspectorate SOP for inspection report writing, NMRA
drug Inspectorate guidelines and regulations on GMP
Inspection, the drug inspectors’ handbook, the
national drug inspectorate nominal roll, PIC/S
inspection report format and WHO TRS No. 996 2016,
Annex 4 guidance on GMP inspection report writing.
The data were segregated and analyzed based on the
following variables which are.
a. Information on demographic data of lead 
inspectors of the twenty-five inspection teams. 
a. Educational qualification 
b. Field of study 
c. Years of cognate experience as 
inspectors 




b. Technical content (QMS and Site) 
c. Objective Evidence for non-
compliance statement 
d. Use of third person narrative past 
tense. 
Practice attributes  
a. Risk-based classification of GMP 
deficiencies. 
b. Reference of deficiencies to right 
applicable laws, regulations and 
GMP text 
c. Signing off on a report by members 
of inspection team. 
d    Timely submission of inspection 
       reports 
c. Competence of the inspectors 
a. Knowledge competence 
b. Skill competence 
c. Attitude competence 
 
Data Collation 
The collected data was transcribed using the 
following steps.  
Scoring System for data obtained from Inspection 
report. 
The scoring pattern or marking guide for observation 
made in a particular section of inspected facility, 
involved upward and sequential validation of each 
rubric. {the components or the sub-components or 
criteria} by use of assessment criteria stated in Figure 
4. Using this approach, the rubric of interest was 
described as “available in the facility” or “not available 
in the facility” or “not captured at all in the report”. The 
number of rubrics involved in a particular depth of 
report evaluation directly reflect the strength of 
evidence inspectors used to support observations 




































   
  
        
    
    
  
      
     
   
        
    
      
        




     
       
  
      
       
       
      
     
     
    
        
     
    
    
 
     
     
        
  
        
      
     
 
    
   
    
       
    
    
      
 
  
   
 
     
    
    
      




    
      
    
     
   
        
   
     
    
  






































Approach for Grading Observation
Figure 4
Pattern of Assessment and Grading of Inspectional
Observations
The approach used in grading observations made by
inspection teams is listed as follows,
Approach to Scoring Components of Inspection
Report Attributes
The inspection report quality attributes components
(format, technical content, objective evidence and use
of third person narrative past tense) were scored 
based on a quality score range of zero (no correct
answer) to maximum score of one (1.) The report 
component score was derived from the average sum
up of all the sub-components quality scores that feed
into a particular component of interest.
Approach to Scoring Sub-Components of Inspection
Report Attributes
Here, the score range for a sub-component was also
rated from zero (no correct answer) to maximum.
score of one (1). The sub-component score was
derived from average of sum up of major performance
standards that validate or feed into sub-component of
the report. The criteria used to score a report sub-
component is captured in table 1 and listed as follows,
a. The sub-component that was not captured
in the report and the inspection team is
unaware of major performance standards that
feed into it, will score zero (0). This is because
it showed the inability of the team to identify
the absence of the sub-component of a GMP
system and the team’s failure to report such
uncovered area.
b. The sub-component that was captured in 
the report as not available in the facility, but 
the team talk about all (not some of) major
performance standards that feed into the
rubrics will score one (1). This is because it
showed the ability of the inspectors to identify
a gap that need to be corrected in the facility’s
GMP system.
c. Sub-component that was captured in the
report as “Not Inspected” and the inspection 
team gives acceptable reason in writing for 
such action will score = 1. This is because the
inspection team revealed an unresolved 
compliance issue, which the team for next
inspection visit need to address during the
exercise.
Caution: Such action would be captured in 
the lead inspector’s performance record for
future reference if need be.
d. The sub-component that was captured in 
the report as available (only as a sub-
heading in the report without expounding its
status), but the team cannot identify any of
the major performance standards will score
zero (0). This is because the inspectors were
not able to demonstrate knowledge of such
important validation tools.
e. The sub-component that was not captured in 
the report as present, but the team identify
all the supporting major performance
standards will scored one (1). This is
because the Inspection team demonstrated
their capability to identify a gap that need to
be corrected in the facility’s GMP system.
The same principle applies as the depth of evaluation 
goes down to assessment of the major performance
standards, minor performance standards and unit






     
 
 





























      
      
    
      
     
        
      
   
     
   
     
  
   
     
      
     
  
     
  
  
     
    
 
 
   
  
    
  
     
 
 
      
  
    
   
   
       
       
     
  
  
    
   
    
      
     
    
      
    
     
     
 
   
    
    
    
   
      
    
    
      
       
   
      
     
  
  
     
      
   
















1 Not captured in 
the report
None 0
2 Captured in the
Report
Good 1









5 Not Capture in
the Report
Good 1
Appropriateness of Inspection Reports
Since there is wide variability in audiences that view 
the inspection report, the tone of the report must be
tactful, objective, and constructive. It must be clearly
written with adequate description of all features of an
inspection report. Some readers may want to know
the technical matters as well as the exact regulatory
citations and language. Others may be interested in a 
“broader” picture of the inspection to note trends.
Regulatory agencies need to know precise details
regarding violations noted and evidence obtained 
during the inspection. To achieve this, a great deal of
appropriateness in the design and construction of the 
report is needed to paint complete picture of what 
transpired during the inspection task. In that wise, the
research used the steps mentioned below to assess
the extent each report complied to standards of
inspection report writing practice.
a. Identification of all the report quality attributes, 
their components, sub-components, and
other report’s rubrics.
b. Risk-based classification of GMP deficiencies
observed during an inspection visit was
captured or not captured in the report.
c. Development of grading criteria for report
quality attributes, their components, sub-
components, and other assessment rubrics
d. Application of order of importance factor 
(OOI) to report components to reflect the
relevance of each component and its impact 
on appropriateness of the report.
e. Calculation of each report’s score through
cross-multiplication of average of the sum of
values of components that made up the
coverage attribute with those of the practice
attributes with the use of a risk matrix table.
f. Data generated was classified on the scale
range of {0-3}, {4-6}, {7-9} and {10-12} to
differentiate the reports into categories of;
unacceptable, needs improvement, good,
and excellent reports.
Impact of Intervention Program on Inspectors’
Report Writing Effectiveness
The impact of intervention program was evaluated by
comparing the reports that were written before and
after the intervention program by external GMP
trainers in the study organization. The method
involved selecting two sets of twelve reports that were
written before and after the intervention program 
which took place in a period of three days from 7-9 
November 2018. A two-dimensional approach that
involved; (a) investigating each team performance on 
different report quality attribute and (b) exploring
various teams’ performance on each quality attribute 
element was used. Five different numeric scale range 
were developed and use to assess program’s effect
on inspection teams’ writing effectiveness as shown 
table 2A and 2B. These assessment tools include first
a performance level descriptor that defined inspection
team writing proficiency into four categories (Sender, 
2015). The second tool was a four-point Likert scale
that show the numerical change in the number of
report components that occur at four performance
levels of inspection team. The third one is also a four-
point Likert scale the defined the change in number of
teams at different performance levels during 
assessment of a particular quality attribute. The 
remaining tools are the impact factor ranking scale
and the impact scale which were used in conjunction 
with other tools to generate program impact score on








   
 
   
   
   
   
   
   
   
 
 
   
   
   
   






   
   
   
   
 
     
  
   
     
  
         
   
      
      
    
 
     
      
    
   
     
  
 
   
 
     
    
     
     
   
    
       
      
      
     
      
      
      
   
    
    
      
     
     
    
     
      
      
  
     
    
    
    
      
    
      
       
   
     
        
   
      
     
     
      
13 
Table 2A
Program Impact Evaluation Tools
Teams’ Performance Level Descriptors
S/N Performance Level Scale
Score
1 Very under normal 0-25%
2 Under normal 26-50%
3 Normal 51-75%
4 Above normal >75%
Change in Number of Team(s)
S/N Change in Number of Teams
at Various Performance Levels
Scale
Score
1 Insignificant change 1-3
2 Slight change 4-6
3 Significant change 7-9
4 Substantial change 10-12
Change in Number of Report Component(s)





1 Insignificant change 1-2
2 Slight change 3-4
3 Significant change 5-6
4 Substantial change 7-8
Impact on Various Inspection Teams’ Performance on
each Quality Attribute Element
This pattern of evaluation involved examining how the
various teams performed on a particular
subcomponents/component of an inspection report. 
Changes were observed in the number of team(s) at
different performance levels after the program. The 
change occurred as either an increase or a decrease
in the number of team(s) at the four levels of 
performance used to assess each team’s knowledge
of a particular subcomponents/component. An
increase in the number of teams on any performance
level except very under normal, signifies the program
made positive impact in relation to concerned quality
attribute element under review. A decrease showed
the opposite. No change in number of teams on a 
particular performance level signified no impact on
concerned quality attribute element. 
Impact on each Inspection Team Performance on 
various Report Quality Attribute
This approach involved reviewing the change in 
number of quality attribute elements at each 
performance level of an inspection team. In this case,
investigation into changes in the number sub-
components of technical content (the seventeen 
elements of GMP) at the four performance levels was
carried out first. Then, the results generated from
these changes were used to calculate changes in 
number of the report’s components at the four
performance levels. The change in the number of
individual components were used to show how many
components existed at the four performance levels
after the training effort, and each team’s performance
rating on a particular component.
Moreover, a quadrant matrix of components’
performance levels in each team’s inspection report
as column title and change in number of report
components as row title was developed. (Please see 
Appendix entitled “Program Impact Analysis Matrix on
Team’s Ability to explain Status of Report
Components”). The impact of the program on each 
team’s descriptive ability on report components was
assessed by relating changes in number of report
components (increase or decrease) to components’ 
performance level(s) in each team’s inspection report.
An increase in the number of components at above 
normal level of performance indicate that the 
concerned team possess best possible descriptive 
potentials over a wider coverage of report
components. But in a situation where they skewed 
towards very under-normal level of performance, the
reverse is the case. In any quadrant where change in
number of components overlaps a performance level, 
that area defines the nature of impact on inspection
team writing effectiveness. The formular used to
compute the program’s impact on overall
performance of each team is described as follows.
The values of change in number of report component
at four performance levels were multiplied exclusively





      
      
      
       
     







   
   
   
   
 
   
 
    
   
    
   
 
    
  
   
    
    
    
       
     
      
      
     
     
 
   
    
     
   
   
   
      
      
      
     
     
   
 
       
        
    
   
   
     
      
  
     
      
   
        
  
   
     
  
    
  
 
      
      
   
        
    
      
    
    
  
      
     
    
    
      
     
         




divided by the total number of performance levels and
ultimately sum up to give program’s impact score on 
each inspection team. The result obtained was
measured on the impact scale to interpret the nature
of impact the program had on the team’s overall 
performance. See Appendix 8 for detailed result on
Impact Score Calculation for each Inspection team.
Table 2B
Program Impact Evaluation Tools
Impact Factor Ranking
S/N Performance Level Impact 
factor
1 Very under normal 1
2 Under normal 2
3 Normal 3
4 Above normal 4
Impact Scale
S/N Nature of Impact Scale
Score
1 Strong Impact 7.00-8.00
2 Moderate Impact 5.00-6.00
3 Weak Impact 3.00-4.00
4 No Impact 1.00-2.00
A Comparative Study of Reports’ Compliance with
International Standards and Regulatory Guideline
on GMP Inspection Report Writing
Here, the assessment of each report compliance level
with the requirements of the three regulatory
standards for inspection report writing was carried out.
The basic underlying principle in this analysis focused
on content variation of quality attribute elements in the 
three guidance documents. The difference in contents
of report format and the submission timeline in the
three documents served as the main indicator
assessment tool for measuring each report level of
compliance. The varying format sub-components
include introduction, scope of inspection, key
personnel met during inspection, inspection findings
and observations made, and product sample taken
during inspection. For submission timeline of an 
inspection report, ten calendar days was set aside by
the study NMRA while the other two r organizations
have theirs as thirty calendar days. The first step of
data analysis process involved the calculation of
compliance percentage of all the quality attributes
elements. This include the compliance percentage of
quality attribute elements that are content wise the
same, and those that are content wise different in the 
three guidance documents. A scale score of 0 – 25 as
very low, 26-50 as low, 51-75 for moderate and > 75
for high compliance was subsequently developed. 
The grading scale was used to measure the 
compliance percentage of each quality attribute
element. (Inclusive of format subcomponents and
submission timelines) with the requirements of the
three standards. The relevance of each report
component and their individual impact on report
appropriateness was calculated by application of
order of importance factor or weight factor (OOI).
Then data gained from the later was multiplied with
the compliance percentage of each report component 
to generate compliance score of each inspection 
report. Each report compliance score was rated on
compliance Likert scale of {0-2}, {3-5}, {6-8} and {9-
11} and used to determine their compliance levels.
Evaluation of the Lead Inspector’s Competence
Following the general opinion that fresh inspectors
cannot easily assess pharmaceutical GMP, the
research assumed that the performance of an
inspection team strictly lies on the proficiency of the
team lead. This is because there is reasonable belief
that he is experienced in conformity determination. He
is a guidance counsellor on regulatory and 
organizational requirements that promote product
quality. He supervises team of regulatory inspectors. 
Thus, a failure on his part, would have an
overwhelming effect on the team’s performance
during inspection. In this instance, the research
sought to know the impact of intervention program
conducted by external GMP trainers on the
proficiency of lead inspectors of twelve inspection
teams selected from the study NMRA. The method of






      
      
      
     




       
     




           
   
      
      
    
      
    
      
         
    
      
      
     
     




    
    





   
   




    
 
      
         
     
     
      
    
     
  
 
       
    
   
       
   
     
       
  
   
   
  
  
      
        
     
  
 
    
    
 
     
     
    
  
   
      
        
 
 
       
  
   







This was defined as lead inspectors’ knowledge of
accepted report format, technical content (QMS and
site) of the report, the use of objective evidence to
substantiate observations made during inspection
and the use of third person narrative past tense in
their report.
Skill competence 
This speaks to lead Inspectors’ ability to assign risk
level to GMP observations Next is their expertise to 
cite applicable laws or GMP text that substantiate 
observed violations. 
Attitude competence
This points at the ability of the team lead to ensure the
report is properly written, endorsed, and submitted
within timeframe as stipulated by the study NMRA
inspector’s guide. The difference in values of lead
inspectors’ knowledge, skill, and attitude competence
before and after intervention program was used to
compute changes in their abilities to write effective
report. A score range of one as maximum value (ideal
value) and any value from 0 – 1 for current values was
used as grading criteria for lead inspector’s
competence. This was further illustrated by use of a
four-point bi-polar Likert scale captured in table 3.
Competence score was computed by adding up the
values of knowledge, skill and attitude competences
and divide it by sum up of all report components’
assigned weights.
Table 3
Scale Score for Inspectors’ Competence
S/N Likert Scale Competence level
1 0.00-0.25 Novice or never meet 
expectation
2 0.26-0.50 Advanced beginner 
or far below
expectation
3 0.51-0.75 Partly competent or 
near expectation
4 0.76 – 1.00 Competent or meet
expectation
Gap Analysis of Inspection teams’ Report Writing
Ability 
The study involved definition and comparative
analysis of gaps in the inspection team’s ability to
describe observations made during inspection. The
different teams’ performance gaps were assessed
and categorized based on their expertise in reporting
the status of various technical components and 
subcomponent of a GMP system. Steps taken to
accomplish the task is listed as follows.
.
• Establishing a benchmark of not less than
75% as minimum score that depicts proficient 
performance of an inspection team. This was
derived from cut score of not less than 75%
which stood as proficiency grade in the study
NMRA procedure on writing inspection report.
• Finding the key components of the report
which are technical content, objective 
evidence, risk-based classification of
deficiencies, reference of violations to the 
right GMP text etc.
• Establishment of the competence gap levels.
• Lastly, identification of gaps displayed by the
various teams in the act of drafting their
inspection reports. (Han van loon, 2004)
(Please see table 4 for detailed information)
The different levels of competence gap exhibited by
inspection teams in the act of writing inspection report
were defined as follows: 
Substantial gap: When more than 75% of the total
inspection teams score less than 75% for any
parameter of the report. The gap associated with the
teams’ performance is termed substantial gap.
Significant gap: When between 51% to 75% of
inspection teams, score less than 75% for any quality
attributes of the report. The gap associated with the
teams’ competencies is termed significant gap.
Slight gap: When between 26% to 50% of inspection
teams, score less than 75%. The gap is termed Slight
gap.
Insignificant gap: When between 0% to 25% of the
total number of inspection teams, score less than 75%.
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Table 4
Definition of Inspection Teams’ Performance Gap
S/N Performance 







1 >75% of total
number of teams






2 Between 51% to 
75% of total
number of teams











quality attribute or 
sub-component
6 -12 Slight gap
4. Between 0% to 
25% of total
number of the 
teams scored <
75% for any
quality attribute or 
sub-component




The collected data were entered and analyzed using
SPSS software program frequency distribution tables.
Chi-square tests were used to test association
between categorized variables. The research used a
sampling technique by which inference was drawn
from values of analyzed sample and generalize to
show proficiency of the Agency’s inspector in the act 
of report writing.
Limitations of the study
The initial plan of using sample size of fifty inspection 
reports was not possible because of limited number of
the types of inspection reports (pre-registration
inspection report and GMP re-assessment inspection
report) needed for the study. Consequently, the 
researcher resolved to use lesser sample size of 
twenty-five reports which was the quantity accessible
on the inspectorate data base. The name of the
organization was not disclosed due to its
management policy (Birna et al, 2016). The study was
not restricted to inspection report of a particular drug 
formulation report like oral solid dosage, oral liquid
dosage, external preparations etc.
The research did not investigate the effectiveness of
inspection teams’ conclusive statement on audited
facility GMP status. This statement was usually
categorized as satisfactory, marginal, and 
unsatisfactory with granularity that provide
information on whether the facility cGMP status is of
high, medium, or low risk rating (TGA, 2016). The
study did not investigate the establishment inspection
reports based on actions taken because of
observations. This implies categorizing the reports
into No Action Required, Needs Improvement and 
Official Action Required inspection report. This is
because such practice had not been initiated by the
study NMRA as at the time of this research.
3. RESULTS AND DISCUSSION
The research was a retrospective study of twenty-five
GMP inspection reports of a National Medicine
Regulatory Authority somewhere in West Africa
designed to assess the inspectors’ proficiency in the
act of inspection report writing.
Impact of Demographic Characteristics of Lead
Inspectors on their Teams’ Writing Effectiveness
In Appendix 1, the result indicated that of the twenty-
five reports used in generation of research datasets, 
only one (4.0%) qualified as excellent report. Two
(8.0%) were reported as good reports. Needs
improvement reports and unacceptable reports were
each eleven in number (44.0%). Of eleven (44.0%)
unacceptable reports, seven (63.6%) were written by
inspection teams whose team leads held bachelor’s
degree while the remaining four (36.4%) were drafted
by teams whose lead inspectors possess MSc





     
       
  
      
    
      
    
     
        
     
     
    
       
         
        
     





        
    
   
   
  
     
 
 
   
    
      
    
   
   
      
   
   
   
 
      
     
         
    
      
       
      
     
   
       
     
     
       
     
  
 
    
     
        
         
      
       
     
     
        
     
     
  
        




      
    
    
   
      
      
      
    
    
   
      
      
       
   
       
      
     
       
  
17 
a PhD holder wrote a good report. None of the good
reports was written by teams whose leaders were
non-pharmacists. Rather, most non-pharmacist lead 
inspectors [3 of 4 (75%]] and their teams authored
unacceptable reports. A review of lead inspectors’
years of cognate experience, put the figure at five or 
more years. Hence, much expertise was anticipated
in their ability to organize an effective report. But this
was not so as most of the unacceptable reports [8 of
11(72.7%)] were written by teams whose lead
inspectors had more than 15 years cognate 
experience. Only [ 1of 10 (10.0%)] lead inspectors
with more than fifteen years of cognate experience
wrote a good report with his team. As the remaining
good report was drafted by a team whose lead
inspectors’ year of cognate experience, did not
exceed ten years. (Please refer to Appendix 1)
Appropriateness of the Reports
a. Excellent Report
Coverage Status
The excellent report [1 of 25(4.0%)] (Report number 
12) had a format that meet expectation. Review of the 
report show that the inspection team had excellent
knowledge of the technical content. The writers of the 
excellent report demonstrated partial mastery in the 
use of objective evidence. The team also displayed 
good use of third person narrative past tense in their
act of writing inspection report.
Practice Status
Analysis of the practice aspect of inspection report 
writing, shows that the authors of excellent report 
correctly assigned risk level to more than 75% of GMP
deficiencies they saw during the inspection visit.
Further review revealed that more than 75% of these 
deficiencies were appropriately alluded to the right 
GMP text. The excellent report was signed off by all
members of the inspection team. Nevertheless, the 
report was not submitted in a timely manner.
b. Good Reports
Coverage status
All the good reports [2 of 25 (8.0%)], (Report number
17 and 25) had format that meet expectation. Findings
in one of the two (50.0%) good reports showed the
authors had excellent knowledge of the technical
content. All the same, the authors of the remaining
good report (50.0%) possess just good knowledge of
it. One of the two teams (50.0%) that wrote good
reports displayed partial mastery in the use of
objective evidence. As the remaining one (50.0%)
showed emerging mastery in its use. One of the two
teams (50.0%) that drafted the good reports
demonstrated good use of third person narrative past
tense while the team that authored the remaining
good report (50.0%) made excellent use of third 
person narrative past tense.
Practice Status
The two good reports demonstrated adequate
assignment of risk levels to violations in the range of 
51- 75%. In terms of referring observed violations to
the right GMP text, One of the two good reports had
51- 75% of observed deficiencies adequately tied to 
the right regulatory text. The remaining good report
had between 26-50% of the violations alluded to the
applicable guidelines or regulations. Under signing off
on an inspection report, one of the good reports was
endorsed by all members of the inspection teams
while the other one was not authorized. Lastly, the
practice component of timely submission of report, 
revealed that only one (50.0%) of the two good reports
(Report number 25) was submitted within the
approved timeline.
c. Needs Improvement Reports 
Coverage Status
Data analysis revealed that all needs improvement
reports [11 of 25(44.0%) inspection reports], (Report
number 7, 8, 9, 15, 16, 18, 19, 21, 22, 23 and 24) had
format that meet expectation. Five of the eleven
(45.5%) teams that wrote the needs improvement
reports had good knowledge of the technical content
as the teams that wrote the other six (54.5%) needs
improvement reports had fair knowledge of the 
component. Two of the eleven (18.8%) teams that
authored needs improvement reports demonstrated
partial mastery in the use of objective evidence. Six
of the eleven (54.5%) teams displayed emerging
mastery while the remaining three (27.7%) showed no
mastery in the use of objective evidence. Still on 
needs improvement reports, four of the eleven
(36.4%) teams confirmed good use of third person 
narrative past tense, 6 of the eleven (54.5%) teams
needs practice even as the remaining one (9.1%)






    
   
       
      
    
     
    
      
      
     
     
    
     
     
   
     
      
     
       
     
       
    




   
     
         
   
    
  
      
      
      
     
    
     
   
      
       
       
     
       




   
      
        
     
       
  
        
     
      
        
     
      
   
     
      
      
      
       
       
      
   
      
     
      
  
 
   
    
        
    
      
    
     
      
  
    
    
      
     
       
     
     
     
      
        
         
   




Eight of the eleven (72.7%) needs improvement 
reports, had adequate risk-based classification of
more than 75% of GMP violations observed during
inspection. Two of the eleven (18.2%) needs
improvement reports had adequately classified
deficiencies in the range of 51-75%. For the remaining
report, the scale range of adequately classified
violations lied between 0-25% of the total number of
deficiencies. Four of the eleven (36.4%) needs
improvement reports had more than 75% of observed
deficiencies adequately referred to the right regulatory
citation, Three out of eleven (27.3%) needs
improvement reports had between 51-75% of their
individual deficiencies properly cited. The remaining
4(36.4%) needs improvement reports had between 
26-50% of the observed deficiencies properly
referenced to the right regulatory standard. Eight of
the eleven (72.7%) needs improvement reports were 
signed off by all members of the inspection team, 
1(9.1%) of needs improvement reports was not
signed off by all members of the team and remaining
2(18.2%) were not signed off at all. Lastly, all but two
of the eleven (18.2%) needs improvement reports
were not submitted in a timely manner.
d. Unacceptable Reports
Coverage Status
Eleven [11 of 25 (44.0%) Inspection reports] 
unacceptable reports (Report number 1, 2, 3, 4, 5, 6,
10, 11, 13, 14, and 20) had format that meet
expectation. For other coverage components, only
one of the eleven (9.1%) teams that authored
unacceptable reports demonstrated excellent
knowledge of the technical content. Five of the eleven 
(18.2%) teams possessed fair knowledge and poor
knowledge of technical content was associated with
the remaining eight (72.2%) teams that authored
unacceptable reports. One of the eleven (9.1%)
unacceptable reports confirmed that the authors had
partial mastery in the use of objective evidence while
the other ten (90.9%) teams had no mastery in the use 
of the component. Out of the eleven teams that wrote
unacceptable reports, two (8.2%) made good use of
third person narrative past tense. One (9.1%) needs
practice, and the remaining eight (72,7%) teams
made no use of it.
Practice Status
Outcome of eleven unacceptable reports revealed
that two (18.2%) had adequate risk-based
classification of more than 75% of observed GMP
violations. One of the eleven (9.1%) unacceptable
reports had correct assignment of risk level to an
observation in the range of 51-75%. Another report
had its own in the range of 26-50%. The remaining
seven (63.6%) unacceptable reports revealed proper
assignment of risk levels in the range of 0-25%. On
issue of citing appropriate regulatory text, one of the
eleven (9.1%) unacceptable reports had between 26-
50% of observed deficiencies properly alluded to the 
right GMP text. Remaining ten (90.9%) unacceptable 
reports revealed that 0-25% of the GMP deficiencies
was adequately referenced to right GMP text. Most
unacceptable reports [9 of 11(81.8%)] were signed off 
by all the members of inspection team. One (9.1%)
unacceptable report was not signed off by all
members of the team just as the remaining one (9.1%)
was not signed off at all. Four of the eleven (36.4%)
unacceptable reports were submitted in a timely
manner whereas the remaining seven (63.6%) were
not received within the approved timeline. See
Appendix 3 entitled as “Data on Quality
Characteristics of Inspection reports.
Conclusively, among the twenty-five inspection
reports that were selected for the study, one qualified
as an excellent report, two (12%) were categorized as
good reports. Needs Improvement reports were
eleven (44%) in number, and the remaining eleven
(44%) were unacceptable reports. (See Appendix 4 
and Figure 5 for study NMRA Inspection Reports’
Classification and their Scores). Team 12 made the 
best performance in the act of writing inspection 
report in that they scored not less than 75% in four
key components of inspection report. These
components were technical content, third person
narrative past tense, reference to right GMP text and
signing off on a report by members of inspection
team). The same result was recorded in seven of the
seventeen (41%) sub-components of the technical
content. On the contrary, the team’s weak point was
in the practice of late submission of report which has
the risk of causing delay in marketing authorization
issue. Team 12 was followed by team number 25 and
17 which earned the second and the third place with
the data measured during the study.
19 






























    
 
      
      
     
    
     
     
     
    
         
        
  
    
   
     
   
    
    
    
     
     
     
  
     
    
    
       
      
     
     
      
   
   
    
        
   
    
       
      
    
  
     
       
      
       
         
         
   
    
      
     
      
     
       
    
     
     
      
 
      
     
   
     
       
      
         
  
 
     
    
     
    
 
   
   
   
  
    
   
Figure 5
Summary on Inspection Teams Performance in
relation to Appropriateness of the Reports
The report authored by team 11 was found to be the
most unacceptable report. This is because it had a
score of less than 25% in fifteen of the seventeen
(88%) technical content sub-components. Also, the
report scored less than 25% in other coverage
attributes except in inspection report format. Lastly, 
team 11 report had less than 25% in each of the three
components of report practice attributes except for
signing off on an inspection report by members of
inspection team. This was preceded by team 13 and
5 reports. 
Impact of Intervention Program on Inspectors’ 
Report Writing Effectiveness
Impact on Various Inspection Teams’ Performance on
each Quality Attribute Element
The analysis obtained from assessing impact of 
training program on inspectors’ writing proficiency
showed an increase in the number of teams
performing at above normal level of performance. The
increase was clearly observed from the difference in 
the values of report components like technical content
{1of 12(8.3%)}, third person narrative past tense {1of 
12(8.3%)}, risk-based classification of GMP
deficiencies {3 of 12 (25%)}, Reference of deficiencies
to applicable laws, guidelines etc., {3 of 12(25%)} and
timely submission of report {1 of 12(8.3%) before and
after the intervention program. A decrease in the
number of teams by (16.7%) was noticeable on behalf
of signing off on an inspection report, component.
Besides, no change in number of teams was seen 
from the values of format component and the use of 
objective evidence component. Program impact on
various teams’ performance at very under normal
level, showed a decrease in number of teams for
values of all report components except format and 
timely submission of inspection report. More detailed
description of how the various teams described the 
status of inspected facilities was captured in partly in
Figure 6 and fully in Appendix 6, 7 and 8 as follows.
Technical content:
Inspectors’ writing effectiveness of report technical
content showed a significant change in the number of
teams exhibiting very under normal level of 
performance. This was evident by the decrease in the
number of teams on this level of performance from a
figure of {8 of 12(66.7%)} before the capacity building
program, to a value of {0 of 12(0.0%)} after the
program. Also, an Insignificant change, and a slight
change were observed in two group of teams
displaying above normal and normal levels of
performance. These changes manifested as an
increase in the number of teams from values of {1of 
12 (8.3%)} and {1of 12 (8.3%)} before the program, to
{2 of 12(16.7%)} and {(5 of 12(41.7%) after the
program. Teams exhibiting under normal level of
performance on technical content witnessed an 
insignificant increase by {3 of 12(25%)} teams.
Among the seventeen elements of cGMP,
pharmaceutical quality system, material management
system, premises and documentation and procedure
were identified as subcomponents of technical
content, with slight change in the number of teams
performing at above-normal level. Over this, the 
change was recognized as an increase from values of
{2(16.7%)}, {2(16.7%)}, {1(8.3%)} and {1(8.3%)}
before the program to {8(66.7%)}, {8(66.7%)}, 
{5(41.7%)}, and {5(41.7%)} after the training program.
Insignificant changes in the number of teams
exhibiting above-normal level of performance were
noticeable in all other technical content
subcomponents except for training, 
sanitation/personal hygiene, and good practice in
quality control subcomponents. No change in the 
number of teams was witnessed among these 
subcomponents. At normal level of performance, the 
highest change in the number of teams played out in
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20 
Figure 6
Sum changes of Inspectors’ writing performance with respect to the various components of inspection report
before and after the capacity building program 
component. Last of all, decrease in number of teams
on above-normal level of performance after the
intervention program was associated with equipment
component.
Objective Evidence
On behalf of this component, there was an
insignificant increase in the number of teams at
normal level of performance from a figure of {2 of
12(16.7%)} prior to the program to a value of {3 of
12(25.0%)} after the exercise. At above-normal level
of performance, no change was observed before and 
after the program in the number of teams that used
objective evidence in their report. Lastly, data
available for under normal level of performance
revealed a slight increase from a figure of {1 of
12(8.3%)} before the training activity to {5 of
12(41.7%)} after the exercise.
Third Person Narrative Past tense
An appraisal of this verb tense showed there was a
significant decrease in the number of teams with very-
under normal level of performance in the use of third
person narrative past tense. This change was
confirmed by a shift in value from {8 of 12(66.7%)},
prior to the intervention effort to {1 of 12(8.3%)}, after
the activity. At above normal and normal levels of
performance, an insignificant increase of 1(8.3%) and
2(16.7%) was equally observed in the teams’ use of 
the right tense and voice. Lastly, data from under






     
  
    
   
     
    
    
   
      
       
    
    
    
 
     
    
      
    
      
     
     
 
     
   
 
        
   
      
         
      
 
      
     
   
     
       
      
 
  
   
    
     
    
     
     
      
    
   
   
 
  
     
     
   




      
     
     
       
  
     
   
     
   
   
     
     
      
     
    
    
 
   
 
      
     
      
   
     
      
     
     
     
      
    
        
      
       
21 
of four (34.0%) after the training program.
Risk- Based Classification of GMP
Deficiencies
The impact of the intervention program revealed
an insignificant increase in number of teams
properly assigning risk level to GMP violations. 
This was notable at above-normal, normal, and
under-normal levels of performance where
increase of not more than three (25.0%) teams
occurred. Finally, a slight decrease was witnessed
in the number of teams at under-normal level of
performance from a value of 6(50.0%) prior to the
training effort to one (8.3%) after the event.
Referring GMP Violations to the Right
Regulatory Text
On issue of citing applicable laws, regulations and
guidelines that substantiate observations made by
inspectors, the number of teams at normal and
under-normal levels of performance recorded a
slight increase. This was proven by the change in
value from two (16.7%) and zero (0.0%) before the
program to five (41.7%) and 4 (33.3%) after the
exercise. Moreover, improvement in the number of
teams at normal level of performance recorded an
insignificant increase of one (8.3%).
Signing Off on an Inspection Reports
A close look at signing off on an inspection report
indicated a decrease in the number of teams at
above normal and normal levels of performance.
This was confirmed by the change in figures from
nine (75.0%) and one (8.3%) prior to capacity
building event to seven (58.3%) and 0(0.0%) after
the exercise. Besides, no change in the number of
teams performing at under-normal level of
performance occurred. last of all, an increase in
the number of teams at very under normal level
moved from value of one (8.3%) before the
training exercise to three (25%) after the coaching
meeting.
Timely Submission of Inspection Reports
For this report component, there was an
insignificant decrease in the number of teams that
displayed very under normal level of performance. 
This downward trend was reflected in reduction
from eight inspection teams (66.7%) in the pre-
training phase to half (six) of the team (50.0%) in
the post-training phase. This caused an increase
at the above-normal level of performance though
it was insignificant change {1(8.3%)} when
compared with changes at other levels of
performance.
Impact on each Inspection Team Performance 
In this section, the impact analysis on inspection
team’s writing effectiveness were considered in
two ways which are effect on components of each
inspection report and overall effect on each
inspection team performance.
Effect on each Inspection Team Performance on
Report Quality Attribute Elements
The program impact at four levels of performance
revealed that no substantial increase in the
number of components was recorded at above-
normal level by any of the twelve inspection teams.
The strong impact felt by team four (T4 ) at above-
normal level of performance was occasioned by
significant increase {5 of 8(62.5%)} in the
components they effectively described during their
report writing exercise.. Team twelve (T12) 
recorded low impact in their writing abilities due to
a slight-change {3 of 8(37.5%)} they experienced
in the number of components at above-normal
level of performance. Last of all, the program
made no impact at above-normal performance
levels of five teams which are team number three,
five, six, nine and eleven (see Appendix 7 and 8)
Effect on each Inspection Team Overall
Performance
The outcome of program impact evaluation on
each inspection team writing effectiveness was
not an outright success. This is because the
impact felt by each inspection team was less than
optimal. For instance, data on the best impact
{Impact score (IT) = 6.25} the program produced,
was recorded in two inspection teams. According
to this result, it was quite clear that both teams
(team four (T4) and team twelve (T12)) experienced
moderate impact in their writing ability. A weak
impact on report writing effectiveness was evident
in the performance of six other inspection teams
which are; team (T1), (T5), (T6), (T8), (T9 ) and (T10).





     
 
   
    
    
 
    
 
    
   
   
    
     
      
   
   





     
  
  
    







   
    
   
   
    
     
   
    









remaining four teams. (Please see Appendix 8 for
more information).
A Comparative Study of Reports’ Compliance
with NMRA Guideline, WHO Model and PIC/S
Requirements on GMP Inspection Report
Writing
Components of inspection report like technical
content, use of objective evidence, third person
narrative past tense, risk-based classification of
observed deficiencies and reference of violations
to the applicable GMP text, which are content wise
the same in the three guidance documents were
not core indicators in the analysis of individual
report’s compliance. The reverse was the case for
some report format subcomponents and
submission timelines which are content wise
different in the three guidance documents. Only
those format sub-components (headings and sub-






















Number of Inspection reports 
Compliance Status of Inspection Reports 
Level of compliance with NMRA Guideline 
Level of compliance with WHO standards 
Level of compliance with PIC/S requirements 
Figure 7
Comparative study of reports compliance level with NMRA guideline, WHO Model and PIC/S Requirement for
Writing cGMP Inspection Report 
three guidance documents and submission
timelines, were used to assess each report’s level
of compliance. The five subcomponents and the
submission timeline used in verifying this research 
goal are listed as follows.
Compliance Status of Quality Attribute Elements
with the three Reference Standards
Determination of Percentage Compliance of
Report Components that are Content Wise the
Same in the Three Guidance Documents
The percentage compliance demonstrated by
other report quality attribute elements except
format subcomponents and submission timelines,
were the same for the three reference standards.
This is because unlike some format sub-
components and submission timelines which
showed content variation in the three guidance
documents, these quality attributes elements







     
  
     
      
   
   
 
 
   
      
    
    
      
   
       
      
     
    
    





       
      
   
     
     
  
   
      
    




    
     
      
      
    
     
      
       





   
      
     
     
      
     





     
    
      
    
     
    
    
   
 
     
    
    
       
     
   
    
     
   
    
     
     
       
       
      
     
 
   
   
  
     
    




Determination of Percentage Compliance of
Report Components that are Content Wise
Different in the Three Guidance Documents
Only those format subcomponents (headings and
subheadings) which vary content wise across the
three regulatory standards and the submission
timelines were used during the study.
Format Subcomponents
Introduction
Of the twenty-five inspection reports, twenty-three
(91%) showed high level of compliance to
elements of introduction stipulated by study
NMRA guideline on inspection report writing. 
Twenty-four (96.0%) reports had similar level of
compliance with PIC/S perspective on what
introductory part of GMP inspection report should.
look like. Moderate level of compliance to WHO
guidance on how to pen down introductory section
were identified in twenty-one (84.0%) reports.
Lastly, low compliance level to NMRA and WHO
standards characterized the introductory section
of report number. 18.
Scope and limitation of Inspection
High level of compliance with WHO requirement
on scope and limitation of inspection was recorded
in the content configuration of the twenty-five
inspection reports captured it. Similar result was
recorded in eighteen (72%) reports level of
compliance with PIC/S position on what scope and
limitation of inspection should contain. Finally,
high level of adherence to NMRA opinion on 
should be the content of scope and limitation of
inspection was confirmed in only seven (28%)
inspection reports.
Key personnel met during Inspection.
In two separate instances, twenty-two (88.0%)
reports showed high compliance levels with WHO
and PIC/S requirements on key personnel met
during Inspection. Similar level of compliance is
apparent in the way the subcomponent was
defined in twenty-five (100.0%) reports that
conform to NMRA opinion. Report number 10 had
very low compliance with the requirements of
WHO and PIC/S guidelines on what should be the
content of key personnel met during inspection in
an inspection report.
Inspection team’s findings and Observation
On separate occasions, twenty-one (84.0%)
reports revealed high level of compliance with the
three standards requirements on inspection
team’s findings and observation. The remaining
four (16.0%) reports showed moderate level of
compliance with all the three standards. Lastly, no
report exhibited low compliance level with any of
the reference standard need on Inspection team’s
findings and observation.
Product Sample taken during Inspection Task.
High level of compliance with the three reference
standards of writing is obvious in twelve (48.0%)
reports that comply to NMRA guideline. Similar
result was recorded in thirteen (52.0%) reports
that comply to WHO standard. Finally, thirteen
(52.0%) reports that complied to PIC/S opinion on
product sample taken during inspection showed a
high level of compliance.
Submission timeline
The result analysis showed that fifteen (60%)
reports independently showed high compliance
level for WHO and PIC/S standards, Same
compliance level was seen in only six (40%)
reports’ adherences to NMRA standard. In
summary, the compliance percentage analysis of
report format subcomponents and submission
timelines, unveiled the following results. First,
report number. 8 had the highest number of format
subcomponents {(4 of 5(80.0%)} and submission
timelines three (100.0%) that highly complied to
the requirements of the three regulatory standards. 
This was followed by report number 14 and 19
which autonomously have three of the five (60.0%)
format subcomponents and two of the three
(66.6%)} submission timelines revealing high level
of compliance to the reference standards’
requirements. Report number 4 portrayed the
least result with {(1 of 5(20,0%)} format
subcomponent and three separate data on 
submission timeline that never complied to the
requirements of the three reference standards.
(Appendix 10. contains detail dataset on report





   
 
 
       
     
     
    
     
    
     
     
   
       
   
    




    
 
 
      
    
    
    
    
    
     
  
    
  
       
    
    
    
       
     
     
  
       
      
    
      
    
   
   
     
   
      
    
    
    
     
     
   
   
    
       
    
   
    
    




    
  
    
     
     
     
    
   
  
     
      
 
 
   
     
      
 
    
   
   
      
    
   
      
     
    
  
24 
Compliance Status of each Inspection Report with
the three Reference Standards
Compliance scale for scoring the different
inspection reports showed that report number 12
displayed high level of compliance with NMRA and
PIC/S requirements on inspection report writing.
Report number 17 had high level of compliance
with only the PIC/S model. None of the report
showed high compliance with WHO requirement.
Moreover, report number 1 and 5 had the lowest
levels of compliance with the requirements of the
three guidelines on inspection report writing.
Lastly, only two reports had all round compliance
with PIC/S requirements. One report had same
with the NMRA standard and none recorded such
with WHO Model (Please refer to figure 7 and
Appendix 9).
Evaluation of Lead Inspectors’ Competence
Proficiency of Lead Inspectors after Intervention
Program.
Knowledge Competence
Analysis showed that all the twelve (100%) lead
inspectors were competent in the use of approved
format. Two (16.7%) lead inspectors
demonstrated competence in the act of drafting
the technical aspect of the report. Five (41.7%)
were partly competent in constructing technical
section of the report, while the remaining three
(25.0%) never meet expectation (novice). More in-
depth analysis of the technical content), revealed
that more than five lead inspectors (>41%)
displayed competence in the way they assessed
the companies’ premises, pharmaceutical quality
system (PQS) and material management system. 
In this case, eight (66.7%) lead inspectors meet
expectation in their effort to describe the facilities’
pharmaceutical quality system. Another eight
(66.7%) achieved the same level of competence
on material management system. Description of
facility premises was carried out by five (41.7%)
competent lead inspectors. Partial competence on
production & process control and equipment
subcomponents was visible in descriptive abilities
of five (41.7%) lead inspectors. Basic
understanding of sub-components like training
and good practice in quality control were
accomplished by another group of seven (58.3%)
lead inspectors. In the end, ten (83.0%), eight
(66.7%) and six (50%) lead alone never meet
expectation on inspected companies’ sanitation
and hygiene, personnel hygiene, and complaint
management. None of the lead inspectors meet
expectation in their use of the objective evidence
Rather, only three (25%) lead inspectors made
effort to meet expectations (partly competent).
Team No.25 had a team lead with the highest
knowledge competence while the reverse was
noticed with team No. 14 which had a gap value of
0.69. Only one (8.3%) lead inspector ensured a
competent team that wrote their report in third
person narrative past tense. Five (41.7%) lead
inspectors were far below expectation in the use
of the report component. Team 14 lead inspector
was a complete novice in the use of the approved
tense and voice.
Skill Competence
Here, seven (58.3%) lead inspectors
demonstrated competence in risk-based
classification of GMP deficiencies. On behalf of
citing the right GMP text that substantiate
observed deficiencies, only five (41.7%) lead
inspectors meet expectation for the task. Overall,
report number. 24 showed the least gap in skill
competence with a gap value of 0.36. thereby
making them team with the highest skill
competence. The reverse was recorded with team
14 which displayed great deal of knowledge deficit
(Ayu , 2009)
Attitude Competence
Careful review of this aspect of lead inspectors’
competence disclosed that only team 19 and team
20 never meet expectation on signing off on an
inspection report. Alike, ten (83%) lead inspectors
never meet expectation on requirement for timely
submission of report. In conclusion, the result of
lead inspectors’ assessment showed that after the
intervention program, none of team leads
progressed to the appropriate writing competency
profile (>0.75). Eleven (91.6%) lead inspectors
reached level of partial competence (0.51-0.75).
Another lead inspector went on as advanced
beginner (0,26-0.50). and not one remained a
















































Lead inspectors' competence after intervention program 
Novice Advanced Beginner 
Competence level 
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Sum changes of Inspectors ’writing competence before and after the capacity building program.
Overall, there were eleven partly competent
inspection teams and one team at advanced
beginner stage after training exercise. (Please
refer to figure 8 and Appendix 11 for specifics).
Competence of Inspection teams’ lead inspectors
Overall, the competence assessment of twenty-
five inspection teams in Appendix 12, showed
team 12 leader as the only lead inspector with
appropriate writing competency profile. Fourteen
(56.0%) lead inspectors were partly competent.
Five (20.0%) displayed advanced beginners’ skill.
And the last five (20.0%) were novice team leads
in the act of organizing effective GMP inspection
report.
Performance Gaps in NMRA Inspection Report
Substantial Gap
Generally, there was a substantial gap in the way
majority of the inspection teams described the
technical aspect of facility GMP, the use of
objective evidence to support statement of
observation and the use of right tenses and voice
in their report. This was so because more than
75% of Inspection teams (≥ 19) scored an
equivalent value of 75% or less in an effort to air
their view on quality status of the report technical
content or construct report in required tenses and
voice. (Please see appendix 13 for details).
Results in Figure 9 and Appendix 14 highlighted a
substantial knowledge gap in almost all the teams’
observations on fifteen (88.0%) elements of good
manufacturing practice. These included
sanitation/hygiene, complaint, product recall,
contract production and analysis, self- inspection,
training, personnel hygiene, quality control and
good practice in production with six others.
Sanitation/hygiene and training stood out as the
sub-components (elements of GMP), all the
inspection teams {25(100%)} displayed
appropriate writing competency profile. The same
result was recorded among 23(92.0%) teams in
their use of third person narrative past tense. All
the same, substantial gap was not observed














































          
 
 
    
      
        
    
    
   
    
    
     
   
     
    
   
    
   
    
      
  
       
    
   




   
     
       
     
    






Performance gap demonstrated by the teams in the act of writing inspection report 
Significant gap
Significant gap in different teams’ performance
rating was more evident in reports’ components
like technical content, use of objective evidence,
use of third person narrative past tense, reference
of violations to applicable laws and timely
submission of inspection report. For example, in
report components like technical content and use
of objective evidence, two groups of inspection
teams (fifteen (60%) and seventeen (68%) teams) 
autonomously displayed significant gap in their
abilities to write on pharmaceutical quality system
and material management system of inspected
facilities. Furthermore, the same significant gap in
assignment of risk levels to GMP deficiencies and
citing of applicable law or GMP text was evident in
writing abilities of two groups of Inspection teams
(fourteen (56%) teams and eighteen (72%) teams).
Slight gap
The gap level labelled slight gap was not recorded
in any team’s descriptive effort on technical aspect
of GMP and use of objective evidence.
Nevertheless, six teams which could not sign off
on their reports were identified.
Insignificant gap
Except for format component, none of the
inspection teams demonstrated insignificant
knowledge gap in their abilities to evaluate the
status of the other seven components of
inspection report. This implies that future training
need should focused first on use of objective
evidence, the right tenses and voice. (Please see







     
   
  
   
    
    
    
     
    
     
       
  
    
   
   
    
   
     
    
 
      
     
   
    
     
     
      
   
     
    
    
     
    
     
   
   
   
      
    
    
      
     
       
   
       
     
         
   
 
   
       
   
   
  
     
     
   
      
    
     
       
     
      
 
    
        
    
    
     
    
     
       
    




         
   
     
  
     
  
   
    
    
      
     
    
   
      




The research was a retrospective study of twenty-five
good manufacturing practice inspection reports (from
March 2017 through December 2018) of National
Medicine Regulatory Authority, Drug Inspectorate,
somewhere in west Africa designed to assess the
inspectors’ capability and competence in the act of
report writing. In the study, the attribute of effective 
inspection report writing was found to be lacking 
among a good number of regulatory inspectors in a 
National Medicine Regulatory Agencies in West Africa.
The frequency of this problem was learned through
review of selected inspection reports to make the 
following findings. The appropriateness of the reports, 
the impact of intervention program on inspectors’
writing performance, individual reports compliance
status with different models of inspection reports, 
inspection team leader inspectors’ writing
competence and gaps that exist in the act of GMP
inspection report writing among the regulatory
inspectors.
In view of the findings made in this study, the 
conclusions reached are as follows. The results show 
that of the twenty-five inspection teams, one team
(4.0%) wrote an excellent report. Two (8.0%) penned 
good reports. Eleven (44.0%) team drafted needs
improvement reports and the remaining eleven
(44.0%) prepared an unacceptable report. Of eleven
(44.0%) unacceptable reports, seven (63.6%) were 
written by inspection teams whose team leads held
bachelor’s degree while the remaining four (36.4%)
were drafted by teams whose lead inspectors
possess MSc degree. The only team that had the lead
inspector as a PhD holder wrote a good report. None
of the good reports was written by teams whose 
leaders were non-pharmacists. Rather, most non-
pharmacist lead inspectors [3 of 4 (75%]] and their
teams authored unacceptable reports. A review of 
lead inspectors’ years of cognate experience, put the
figure at five or more years. Hence, much expertise
was anticipated in their ability to organize an effective
report. But this was not so as most of the
unacceptable reports [8 of 11(72.7%)] were written by
teams whose lead inspectors had more than 15 years
cognate experience. Only [ 1of 10 (10.0%)] lead 
inspectors with more than fifteen years of cognate
experience wrote a good report with his team. As the
remaining good report was drafted by a team whose
lead inspectors’ year of cognate experience, did not 
exceed ten years.
The outcome of program impact evaluation on each
inspection team writing effectiveness was not an
outright success. This is because the impact felt by
each inspection team was less than optimal. For 
instance, the best impact {Impact score (IT ) = 6.25} 
the program produced was evident in two inspection
teams. More distinctly, the teams (team four (T4 ) and
team twelve (T12 )) individually experienced moderate
impact in their report writing ability. Also, weak impact
on report writing effectiveness was evident in the
performance of six other inspection teams which are;
team one (T1), team five (T5), team six (T6), team eight
(T8), team nine (T9 ) and team ten(T10). Lastly, the
training program had no impact on the remaining four
teams.
In terms of compliance with NMRA guidelines and
model inspection reports (PIC/S and WHO) the study
made this observation. Compliance scale for scoring
the different inspection reports showed that report
number 12 displayed high level of compliance with
NMRA and PIC/S requirements on inspection report
writing. Report number 17 had high level of 
compliance with only the PIC/S model. None of the 
report showed high compliance to WHO requirement. 
Finally, report number 1 and 5 had the lowest levels
of compliance with the requirements of the three 
guidelines on inspection report writing.
An assessment of lead-inspectors competence 
showed team 12 leader as the only lead inspector with
appropriate writing competency profile. Fourteen
(56.0%) lead inspectors were partly competent. Five
(20.0%) displayed advanced beginners’ skill. And the 
last five (20.0%) were novice team leads in the act of 
organizing effective GMP inspection report. Finally, 
substantial gap was notable among the sub-
components of the reports’ technical contents and 
their corresponding objective evidence except for the
pharmaceutical quality system and the material
management system. The same gap was recorded in
almost all {twenty-three (92.0%)} the inspection teams’ 
efforts to use third person narrative past tense in 
report writing. All the same, substantial gap was not










     
   
   
    
    
     
     
    
      
     
 
     
  
    
    
   
  
  
     
    
  
      
    
   
    
      
    
  
      
    
  
     
   
   
      
  
    
    
   
    
     
   
     
       
   
  
 
    
    
       
    
  
     
 
       
  
     
  
 
    
    
     
   
 
    
 
      
    
     
    
     
   
   
  
    
     
     
  
   
  
     
     
     
     
     




5. RECOMMENDATIONS FOR NEXT the NMRA should encourage the use of non-
STEPS public regulatory reports to enhance learning
The study recommended the following: 
and minimize the gaps that exist in their
inspectors’ writing abilities (Garg, S et al, 
.
• Regulatory affairs professionals (NRAs and 2013).
regulated entities) and the academia should 
• The NMRA should release their staff to
collaborate on issue of reviewing pharmacy
and related science school curricula to 
capture training on regulatory sciences. This
will assist young graduates that wish to build
their career in Food and Drug Authority
organization or in drug manufacturing site to
acquire basic knowledge on issues that
border on medicine regulation (Gloria et al,
2019)..
• On occasional basis, The NMRA should
participate in WHO rotational fellowship 
which will provide them with a complete set of
the WHO norms and standards that underpin
prequalification. Moreover, opportunity to 
review and discuss inspection reports with
high profile inspectors will help participants
improve their inspectorate review process
(WHO, Prequalification: WHO rotational
fellowships: an update, 2016).
expose their fresh inspectors and other • Reviewers or more experienced inspectors
cadres of inspectors to short-course intensive should ensure that every claim and response 
writing interventions that is jointly delivered by an inspection team gives must be backed up
cGMP expert organizations and regulatory with objective evidence. This is because 
affairs writing specialists. Content unsupported or poorly explained assertions
components of such training program should will confuse the auditee and cast doubts over 
focus on higher and lower approach of skill- the inspectors’ ability to make accurate
building in effective writing. This includes judgement (AIHO, 2017).
developing the main message, arranging
writing in a sensible way, listening to the • To ensure precision and fairness, the
pattern and flow of the sentences and inspectors should proofread, edit, and re-
paragraphs, choosing effective vocabulary to work where necessary their report before 
communicate meaning, and introducing the submission to ensure there is no issue factual
inspector’s opinion in a way that his audience inaccuracy that could result in dispute of
will understand him (Miller, Cynthia, An-Lin , observations (AIHO, 2017).
& Anita , 2015).
• The Management of the NMRA drug 
inspectorate should carry out periodic
reassessment of the inspectors’ competence
to improve their performance. This should
• The inspectorate should collaborate with one
or two pharmaceutical manufacturing
industries with unswerving history of
compliance with cGMP on issue of short 
course internship programs for their fresh
include a mentorship program which will inspectors. This is because the step will
serve as means for closer monitoring and provide them with practical requirements of
receiving of daily feedback on the progress of what is expected of them as NMRA
their performance. inspectors.
• The study organization should leverage the 
opportunity provided by regulatory reliance
pathway. or mutual recognition agreement to 
expose their staff to joint inspection programs
where they will share their assessments with
other National Regulatory Authorities’
inspectors, gain from each other’s expertise 
and deliberate on any deficiencies in the data 
being evaluated (WHO, Good reliance 
practices in regulatory decision-making: high-
level principles and recommendations, 2020)
• While ensuring adherence to confidential
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Impact of Lead Inspectors’ Demographic Data on their Teams’ Writing Effectiveness
Demographic 
Characteristics










BSc/HND     0[0.0] 2[12.5] 7[43.8] 7[43.8] 16 
MSc 0[0.0] 0[0.0] 4[50.0] 4[50.0] 8
PhD and above  0[0.0] 1[100.0] 0[0.0] 0[0.0] 1` 8.37 0.0770
Total 0 3 11 11 5
Qualification
Pharmacist 0[0.0] 3[14.3] 10[47.6] 8[38.1] 21
0[0.0] 0[0.0] 1[25.0] 3[75.0] 4 0.57 0.1723Non-Pharmacist 
(Scientist)




0[0.0] 1[14.3] 3[68.0] 2[28.6] 611-15years
0[0.0] 1[20.0] 6[66.6] 2[22.2] 9>15years
0.83 0.26560[0.0] 1[10.0] 2[20.0] 7[70.0] 10
Total 0 3 11 11 25







   
 
 
   
 














































   
 
   
   
    












   


















Assessment Guide for Evaluating Quality Characteristics of Inspection Reports
Quality 
Characteristics
Components Sub-components Grading rubrics
Coverage 
Attributes






Technical Content Seventeen elements of WHO cGMP Excellent knowledge
(QMS and Site)












• GMP requirements with high 
proficiency in command of 
evidence 
Non- compliant statement contained.
• GMP requirements for 
manufacture of medicines
• Deficiency






Use of third person Use of third person narrative past tense Excellent use










Proper assignment of risk level to GMP
violations
Improper assignment of risk level to 
GMP violations
Non-assignment of risk level to GMP
violations
More than 75% of violations adequately assigned.
Between 51-75% of violations adequately assigned
Between 26-50% of violations adequately assigned







Proper citing of applicable regulations
Improper citing of applicable 
regulations
Non citing of applicable regulations
More than 75% properly cited GMP violations
Between 51-75% properly cited GMP violations
Between 26- 50% properly cited GMP violations
Between 0- 25% properly cited GMP violations
Signing off on an
inspection report 
All members of the inspection team.
Some members of the inspection team
Not done by any member of the team
Completely signed off on an inspection report
Partially signed off on an inspection report
No signing off on an inspection report
Timely submission
of inspection reports
• Timely submission of report


















                 
 
     
 























       
 
       
 






     
 
     
 






       
 
       
 






      
 
      
 
     
 
 
         
 
 
          
 
          
 
          
 
          
 
 
       
       
       


































































































































































Data on Quality Characteristics of Inspection reports
Quality  
characteristics
Components percentage scale score
{Percentage}
















25 0 0 0
3 7 7 8
0 5 7 13




























12 5 1 7
7 3 5 10














































        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
 
           
          
 
         




















RC1 L1 181217 0.75 1.04 0.78 UR
RC2 L2 22-270317 1.20 1.22 1.46 UR
RC3 L3 100818 1.98 1.20 2.38 UR
RC4 L1 240817 1.18 1.40 1.65 UR
RC5 L4 050218 0.74 1.04 0.77 UR
RC6 L5 240718 1.25 2.05 2.56 UR
RC7 L1 231018 2.38 2.90 6.90 NIR
RC8 L2 29-301118 1.68 3.12 5.24 NIR
RC9 L1 120718 2.21 2.92 6.45 NIR
RC10 L5 010918 1.44 2.48 3.57 UR
RC11 L3 150818 1.20 0.80 0.96 UR
RC12 L1 19-200718 3.00 3.19 9.57 ER
RC13 L2 23-240118 1.14 0.80 0.91 UR
RC14 L6 091118 1.27 1.20 1.52 UR
RC15 L1 8-90818. 2.06 2.60 5.36 NIR
RC16 L7 12-131118 2.19 2.24 4.91 NIR
RC17 L5 14-151118 2.51 3.19 8.01 GR
RC18 L1 22-231118 2.09 2.91 6.08 NIR
RC19 L8 12-131118 2.03 2.12 4.30 NIR
RC20 L1 14-151118 2.86 1.27 3.63 UR
RC21 L3 10-111218 2.67 2.90 7.74 NIR
RC22 L5 12-131218 2.39 2.54 6.07 NIR
RC23 L9 10-111218 2.09 2.56 5.35 NIR
RC24 L1 18-191218 1.64 3.34 5.48 NIR
RC25 L1 13-141218 3.04 2.88 8.76 GR
Note: ER – Excellent Report, GR – Good Report, NIR- Needs Improvement Report, UR - Unacceptable Report, 
RC No. – Report code numbers and L – Company Location, CA – Coverage attribute and PA – Practice attribute
Scale Score - Excellent Report - (12.00 -15.00), Good Report – (8.00 – 11.00), 









    









   
    
 
   







   
 
   
 
      
  









     
   
 









































      
   
   






   











Rubrics for Evaluating GMP Inspection Report
Report
Excellent Good Needs Improvement Unacceptable
Shows consistent command of
standard, grade level proficient 
to writing requirement. Error
free, as such they do not 
disrupt readability and
understanding.
Shows some command of 
standard, grade level
above average to writing
requirements. Errors are so
few and so minor that they
slightly disrupt readability
and understandability. 
Shows scanty command of standard, 
grade level marginal to writing
requirements. Errors are noticeable in
such a way that they significantly
disrupt readability and
understandability in several parts of 
the report.
Shows consistent error of standard, 
grade level unacceptable to writing
requirements. Errors impede both
readability and understandability
Format
Meet expectation Near expectation Not Near expectation Not Acceptable
Followed approved layout that 
should be used for the
preparation of reports
A few errors in the layout
used for the preparation of 
reports
So many format errors as to make
report ineffective
Does not follow specified format
Technical Content
Excellent knowledge Good Knowledge Fair knowledge Poor knowledge
Content is thorough, accurate,
explicit, or covered in as much
depth as expected, and is
proficiently described using
relevant performance.
standards in all sections of the
report.
Content is accurate, and is
reasonably described by
using relevant performance
standards in most sections
of the report
Content is partway accurate, and not
as explicit or covered as expected,
and is not adequately described by
use of relevant performance
standards in different sections of the
report
Content is not accurate or complete, 
and is not described by use of
relevant performance standards in
most sections of the report
Objective evidence
Mastery Partial Mastery Emerging Mastery No Mastery
Expressed using the specific
GMP terms. Use of relevant 
standards of quality. Core
reasoning was drawn from
textual evidence.
Expressed in general GMP 
terms. Use of relevant
standards of quality with
slight gaps. Core reasoning
was partially drawn from
textual evidence
Not expressed in the right GMP 
terms. Use of irrelevant standards of
quality is applied with significant gaps
or misinterpretation. Core reasoning
was tangential or invalid in relation to
the textual evidence.
Not expressed in GMP terms. No 
use of unit quality standards. Core
reasoning showed no idea of 
evidence
Use of third person narrative past tense
Excellent use Good use Needs Practice No Use
The right tense and voice were
incorporated in more than 76%
of the report. Ideas display in a
creative way further enhanced
readers’ understanding
The right tense and voice
were applied in about 51-
75 % of the report and
ideas were comprehensive
The right tense and voice were
incorporated in about 26-50 % of the
report. Also, the ideas were not 
comprehensive enough.
Used only present tenses to









   
 



































   
          
  
 
        
 
 






       





     
 
 
   
 
 
        






    
 







         
    















Before After Before After Before After Before After
Coverage 
1 Format 12[100] 12[100] - - - - - -
2 Technical 1[8.3] 2[16.7] 1[8.3] 5[41.7] 2[16.7] 5[41.7] 8[66.7] 0[0.0]
content
3 Objective 0[0.0] 0[.0.0] 2[16.7] 3[25.0] 2[16.7] 5[41.7] 9[75.0] 4[33.3]
Evidence








2 Reference to 2[16.7] 5[41.7] 1[8.3] 2[16.9] 1[8.3] 4[33.3] 9[75.0] 1[8.3]
the right 
GMP text











Note: The values of the performance parameters (Above normal, normal, under normal and very under normal levels)
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Appendix 7
Program Impact Analysis Matrix on Team’s Ability to explain Status of Report Components






























Strong Impact Moderate Impact
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Appendix 8
Impact Score Calculation for each Inspection team
Ta
Before
A N UN VUN Tb
After
A N UN VUN Tb -Ta
CNC
A N UN VUN IT
Impact
T1a 3 0 0 5 T1b 5 0 2 1 T1b –T1a 2 0 2 4 4.00 Weak
T2a 2 0 0 6 T2b 3 0 1 4 T2b –T2a 1 0 1 2 2.00 Null
T3a 3 0 2 3 T3b 3 1 2 2 T3b –T3a 0 1 0 -1 1.00 Null
T4a 1 1 1 5 T4b 6 1 1 0 T4b –T4a 5 0 0 -5 6.25 Moderate
T5a 3 0 0 5 T5b 3 3 0 2 T5b –T5a 0 3 0 -3 3.00 Weak
T6a 3 1 0 4 T6b 2 0 6 0 T6b –T6a -1 1 6 -4 3.75 Weak
T7a 3 3 1 1 T7b 2 2 2 2 T7b –T7a 1 1 1 1 2.50 Null
T8a 2 3 1 2 T8b 4 4 0 0 T8b-T8a 2 1 -1 -2 3.75 Weak
T9a 3 0 0 5 T9b 3 2 1 2 T9b-T9b 0 2 1 -3 2.75 Weak
T10a 2 0 0 6 T10b 3 0 4 1 T10b-T10a 1 0 4 -6 4.50 Weak
T11a 5 2 0 1 T11b 4 0 2 2 T11b-T11a -1 -2 2 1 -1.25 Null
T12a 2 0 0 6 T12b 5 2 1 0 T12b-T12a 3 2 1 -6 6.25 Moderate
IT - Program impact score on 
each team writing effectiveness.
TP - Total number of 
performance levels
Ta – Team performance status
before program.
Ta – Team performance status
after program.
CNC – Change in number of 
report components at four 
performance levels of an
inspection team
A – Above normal level –
>75%
N – Normal level –
Between 51-75%
UN- Under normal level -
Between 26-50%
VUN – Very under normal level
- Between 0-25%
VA – Impact factor score at above normal level (4)
VN – Impact factor score at normal level (3)
VUN – Impact factor score at under normal level (2)
VVUN – Impact factor score at very under normal level
(1)
CCA – Change in number of report components at A
CCN -- Change in number of report components at N
CCUN - Change in number of report components at UN
CCVUN - Change in number of report components at
VUN
Note
A Negative CCA, CCN value leads to subtraction during 
calculation of IT.
A Negative CCUN and CCVUN does not result in 
subtraction of figure when calculating IT.
Impact score formula
IT = CCA X VA + CCN X VN + CCUN X VUN + CCVUN X VVUN
TP    TP  TP  TP
Impact scale on team writing effectiveness.
Strong Impact - (7.00 -8.00), Moderate Impact – (5.00 – 6.00),



































    
    
 








































Compliance Scale Score Total
High Moderate Low Very low
Compliance 
Scale Score
[9 -11] [6 – 8] [3 – 5] [0 – 2]
Inspection NMRA 1 7 8 9 25
Reports WHO - 6 10 9 25




















   




















   
 
 
   
 

























     


























   
   



































































































Percentage Compliance of Report Components that exhibit Content Variation in the three

















Introduction NMRA 23[92.0]] 1[4.0]] 0[0.0] 1[4.0] 25 
WHO 0[0.0] 21[84.0] 3[12.0] 1[4.0]] 25
PIC/S 24[96.0]] 0[0.0 1[4.0] 0[0.0] 25
Scope and NMRA 7[28.0] 12[48.0] 6[24.0] 0[0.0] 25 
limitation of WHO 25[100.0] 0[0.0] 0[0.0] 0[0.0] 25
inspection PIC/S 18[72.0] 0[0.0] 7[28.0] 0[0.0] 25
Key NMRA 25[100.0] 0[0.0] 0[0.0] 0[0.0] 25 
Personnel WHO 22[88.0] 1[4.0] 1[4.0] 1[4.0] 25
met PIC/S 22[88.0] 1[4.0] 1[4.0] 1[4.0] 25
findings and NMRA 21[84.0] 4[16.0] 0[0.0] 0[0.0] 25 
Observation WHO 21[84.0] 4[16.0] 0[0.0] 0[0.0] 25
PIC/S 21[84.0] 4[16.0] 0[0.0] 0[0.0] 25
Sample NMRA 12[48.0] 0[0.0] 0[0.0] 13[52.0] 25
taken WHO 13[52.0] 0[0.0] 0[0.0] 12[48.0] 25
PIC/S 13[52.0] 0[0.0] 0[0.0] 12[48.0] 25
Submission timeline
Timely NMRA 6[24.0] 0[0.0] 0[0.0] 21[84.0] 25
submission WHO 15[60.0] 0[0.0] 0[0.0] 10[40.0] 25
PIC/S 15[60.0] 0[0.0] 0[0.0] 10[40.0] 25
Note: The values are in numerical form for those before the parenthesis and in percentage for 























      
      
       
      
      
      
      
      
      
      
      
      
   
               
                                                                    
              
                                                                  
                
             
                  
 
           
                                                         
   
    




Competence of Inspection teams’ lead inspectors after intervention program
Team code Kc Sc Ac Competence
score
Proficiency Level
T1b 1.68 1.92 1.20 0.60 Partly competent
T2b 1.27 0.40 0.80 0.31 Advanced beginner
T3b 2.19 2.24 0.00 0.55 Partly competent
T4b 2.51 2.39 0.80 0.71 Partly competent
T5b 2.09 2.11 0.80 0.63 Partly competent
T6b 2.03 1.86 0.26 0.52 Partly competent
T7b 2.86 1.27 0.00 0.52 Partly competent
T8b 2.67 1.64 1.26 0.70 Partly competent
T9b 2.39 2.54 0.00 0.62 Partly competent
T10b 2.09 1.76 0.80 0.58 Partly competent
T11b 1.64 2.54 0.80 0.62 Partly competent
T12b 3.04 1.68 1.20 0.74 Partly competent
Note: a) Score range = from minimum score (0) to Maximum score (1)
b) Range of competence borders: Novice (0.00-0.25), Advanced beginner (0.26 – 0.50),
Partly Competent (0.51-0.75), Competent (0.76-1.00)
c) Kc = Knowledge competence = Sum up of (Value of F x Weight for F) + (Value of TC x Weight for TC) +
(Value of OE x Weight for OE) + (Value of TP x Weight for TP)
d) Sc = Skill competence= Sum up of (Value of RCD x Weight for RCD) + (Value of RRT x Weight for RRT)
e) Ac = Attitude competence = Sum up of (Value of SO x Weight for SO) + (Value of ST x Weight for ST)
Competence Score = Kc + Sc + Ac /Sum up of (Weight for F + Weight for TC + Weight for OE + Weight for TP +
Weight for RCD + Weight for RRT + Weight for SO + Weight for ST)
Where F = format, TC = Technical content, OE= Use of Objective Evidence, TP = Use of third person narrative past tense
RCD = Risk-based classification of GMP deficiencies, RRT= Reference of deficiencies to right applicable laws, 

























      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
       
      
      
      
      
      
      
      
44 
Appendix 12
Competence of Inspection Teams’ Lead Inspectors



















































































































































































































    
 
 



























   
   
45 
Appendix 13
Gap in Teams’ Ability to Report of Status of Quality Attribute Elements














than or equal to 75%
Number of teams ≥
19











and 75% of all the
inspection teams
score less than or
equal to 75%
Number of teams =










reports within the 
approved timeline
16 64.0
3. Slight gap When between 26
and 50% of all the 
Inspection teams
score less than or
equal to 75%
Number of teams =
≥6< x ≤12







and 25% of all the 
inspection teams
score less than  or 
equal to 75%
Number of teams =






    

















   
   
   
    
   
   
   
   
   
   
   
   
   
    












   
   
46 
Appendix 14
Gap in Teams’ Ability to Report Sub-components of Technical Contents
S/N Gap level Benchmark 













than 75% of 









Sanitation and hygiene 25 100.0
Personnel 22 88.0
Training 25 100.0
Personnel hygiene 24 96.0
Documentation and procedure 20 80.0
Qualification and validation 20 80.0
Production and process control 23 92.0
Quality control 23 92.0
Premises 19 76.0
Good practice in production 22 88.0
Equipment 21 84.0
Complaint 23 92.0
Product recall 23 92.0
















Pharmaceutical quality system 15 60.0
Material management system 17 68.0
